Impingement syndrome of shoulder

M13_IMPINGEMENT

shoulder impingement syndrome: Compression of the rotator cuff tendons and subacromial bursa between the humeral head and structures that make up the coracoacromial arch and the humeral tuberosities. This condition is associated with subacromial bursitis and rotator cuff (largely supraspinatus) and bicipital tendon inflammation, with or without degenerative changes in the tendon. Pain that is most severe when the arm is abducted in an arc between 40 and 120 degrees, sometimes associated with tears in the rotator cuff, is the chief symptom. (From Jablonski's Dictionary of Syndromes and Eponymic Diseases, 2d ed)

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M75.4 Cause of death: ICD-10 — M75.4 2 out of 7 registries used, show all original rules.	11646
4. Check minimum number of events None	11646
5. Include endpoints None	11646
6. Filter based on genotype QC (FinnGen only)	11372

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M75
Name in latin: Syndroma angustiarum regionis deltoideae

NAME	M13_IMPINGEMENT
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M754
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M754
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Impingement syndrome of shoulder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	71196	34860	36190
Only index persons	69775	34470	35305
Unadjusted period prevalence (%)
Whole population	1.00	1.00	1.01
Only index persons	1.31	1.27	1.35
Median age at first event (years)
Whole population	52.66	52.70	52.63
Only index persons	52.60	52.65	52.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11372	6116	5256
Unadjusted period prevalence (%)	2.28	2.17	2.41
Median age at first event (years)	53.12	52.09	54.33

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11646: Matched controls
116460

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

12.4

320.8

319

264

SPAT1153

SPAT

Removal of sutures

2.2

313.4

4067

23129

N02BF01

ATC

gabapentin; oral

3.6

312.5

1141

3447

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.0

311.3

566

983

R51.80

ICD-10 Finland

Headache

2.8

308.7

1825

7299

M01AX05

ATC

glucosamine; oral

2.5

307.7

2543

11695

M75.2

ICD-10 Finland

Bicipital tendinitis

12.9

307.7

734

605

M67.4

ICD-10 Finland

Ganglion

5.1

307.7

759

1579

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

4.6

307.7

805

1839

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

8.1

307.7

789

1037

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.7

307.7

3094

13672

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

122.8

307.7

715

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.8

307.7

1498

3509

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

67.9

307.7

1597

272

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

5.5

307.7

1814

3791

M01AH05

ATC

etoricoxib; oral

3.4

307.7

8761

54589

A02BC03

ATC

lansoprazole; oral

2.3

307.7

3769

20080

N02AX02

ATC

tramadol; systemic, rectal

3.9

307.7

6909

31501

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

12.9

307.7

343

273

M25.5

ICD-10 Finland

Pain in joint

3.2

307.7

4754

20488

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

36.9

307.7

619

177

M01AX17

ATC

nimesulide; oral

2.8

307.7

3578

15966

ACC51

NOMESCO Finland

Release of median nerve

3.8

307.7

1189

3361

WX200

NOMESCO Finland

Interscalenous plexus blockade

15.9

307.7

626

414

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

307.7

4333

24478

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.8

307.7

7055

33439

M79.0

ICD-10 Finland

Rheumatism, unspecified

34.2

307.7

573

176

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.3

307.7

1042

2622

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

307.7

4790

27696

L92

ICPC

Shoulder syndrome

7.4

307.7

520

731

L08

ICPC

Shoulder symptom/complaint

4.2

307.7

4026

12891

N02AJ06

ATC

codeine and paracetamol; systemic

2.7

307.7

5728

31150

M02AA07

ATC

piroxicam; topical

2.5

307.7

4822

25935

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

210.0

307.7

5839

555

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

20.2

307.7

657

344

L03

ICPC

Low back symptom/complaint

2.3

307.7

3355

17305

M65.3

ICD-10 Finland

Trigger finger

8.0

307.7

644

843

NBG10

NOMESCO Finland

Acromioplastia

138.3

307.7

1773

151

M77.1

ICD-10 Finland

Lateral epicondylitis

5.1

307.7

1315

2845

M01AH02

ATC

rofecoxib; oral

3.2

307.7

1895

6746

M01AC06

ATC

meloxicam; systemic, rectal

2.8

307.7

5385

27286

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

76.1

307.7

952

136

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

4503599627370496.0

307.7

11644

980

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

52.2

307.7

190

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

12.6

307.7

506

417

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

35.2

307.7

235

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.9

307.7

893

1927

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

6.3

307.7

1510

2695

M48.0

ICD-10 Finland

Spinal stenosis

3.3

307.7

1744

5841

M01AB05

ATC

diclofenac; systemic, rectal

3.0

307.7

8913

60313

M19.0

ICD-10 Finland

Primary arthrosis of other joints

7.3

307.7

2551

4306

G56.0

ICD-10 Finland

Carpal tunnel syndrome

4.3

307.7

2436

6705

NBE45

NOMESCO Finland

Plastic repair of ligament of shoulder not using prosthetic material, arthroscopic

27.0

307.7

392

150

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.2

307.7

1659

5768

N02BE01

ATC

paracetamol; systemic, rectal

3.7

307.7

10769

89313

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.2

307.7

1856

5035

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

64.7

307.7

436

N03AX16

ATC

[U] pregabalin

3.8

307.7

3867

13333

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

5338

32026

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

5.2

307.7

809

1636

N06AA09

ATC

amitriptyline; systemic

3.8

307.7

1494

4298

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

307.7

3095

14567

M01AH01

ATC

celecoxib; oral

3.0

307.7

2709

10714

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

13.9

307.7

1623

1341

M75.1

ICD-10 Finland

Rotator cuff syndrome

15.6

307.7

7136

10729

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

19.7

307.7

595

318

M79.1

ICD-10 Finland

Myalgia

3.3

307.7

1767

5955

ZXA00

NOMESCO Finland

Right side

2.5

307.7

3521

17330

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

13.7

307.7

1589

1327

N03AX12

ATC

[U] gabapentin; oral

4.2

307.7

2725

7859

M54.4

ICD-10 Finland

Lumbago with sciatica

3.4

307.7

2731

9740

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

307.7

3699

18896

M79.6

ICD-10 Finland

Pain in limb

3.6

307.7

5513

23372

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

27.3

307.7

787

308

A02BC02

ATC

pantoprazole; systemic

2.3

307.7

8432

61849

M70.6

ICD-10 Finland

Trochanteric bursitis

3.9

307.7

1959

5679

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

42.4

307.7

1118

291

M79.7

ICD-10 Finland

Fibromyalgia

11.3

307.7

469

430

N06AX21

ATC

duloxetine; oral

3.5

307.7

1667

5311

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.7

307.7

1480

4364

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

5.0

307.7

852

1808

M54.5

ICD-10 Finland

Low back pain

2.8

307.7

4914

23826

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

20.8

307.7

382

190

M03BX02

ATC

tizanidine; oral

2.8

307.7

8360

55343

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.5

307.7

2379

7975

M01AE02

ATC

naproxen; oral, rectal

2.6

307.7

7291

46135

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

306.3

3587

19555

S18

ICPC

Laceration/cut

2.0

298.1

5584

36225

G54.0

ICD-10 Finland

Brachial plexus disorders

7.3

294.7

439

620

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.8

294.2

1687

6629

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

292.7

3663

20432

M54.2

ICD-10 Finland

Cervicalgia

3.5

292.3

1092

3344

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

292.1

3496

19161

M75.5

ICD-10 Finland

Bursitis of shoulder

7.2

285.3

433

624

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

279.9

1613

6345

ZXA05

NOMESCO Finland

Left side

2.2

278.9

3054

16110

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

269.7

2897

15134

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

5.7

261.6

499

906

L15

ICPC

Knee symptom/complaint

2.2

261.3

2925

15507

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

15.7

261.0

226

147

M02AA10

ATC

ketoprofen; topical

2.4

260.9

2094

9650

H02BX01

ATC

methylprednisolone, combinations; systemic

4.1

259.9

747

1906

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.4

259.2

996

3098

H02AB06

ATC

prednisolone; systemic

1.9

258.1

5639

37954

M75.8

ICD-10 Finland

Other shoulder lesions

5.1

256.7

554

1124

M01AE01

ATC

ibuprofen; systemic, rectal

3.3

256.4

10807

92823

R03AC02

ATC

salbutamol; inhalant

1.9

254.1

6353

44632

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

14.3

249.1

227

162

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.6

248.5

1659

7002

L13

ICPC

Hip symptom/complaint

2.3

248.3

2230

10774

M01AB55

ATC

diclofenac, combinations; oral

3.4

246.2

933

2874

G44.2

ICD-10 Finland

Tension-type headache

2.6

238.7

1604

6783

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

237.6

2506

12913

J01AA02

ATC

doxycycline; systemic

2.2

236.3

9340

75831

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

110.2

234.0

120

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.7

232.0

1433

5810

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

226.6

1190

4432

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

21.3

222.0

166

M50.3

ICD-10 Finland

Other cervical disc degeneration

5.6

220.6

429

792

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

4.3

219.3

582

1396

R06.0

ICD-10 Finland

Dyspnoea

2.0

216.4

3017

17189

M77.0

ICD-10 Finland

Medial epicondylitis

6.0

216.0

387

661

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

214.2

2071

10260

L01

ICPC

Neck symptom/complaint

2.3

213.1

1796

8395

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

213.0

2197

11168

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

5.5

212.4

423

798

L17

ICPC

Foot/toe symptom/complaint

2.0

211.4

3204

18771

R52.2

ICD-10 Finland

Other chronic pain

4.8

210.3

492

1067

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.3

210.3

1769

8259

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

210.2

2678

14747

M54.6

ICD-10 Finland

Pain in thoracic spine

3.1

209.5

940

3201

L12

ICPC

Hand/finger symptom/complaint

2.3

209.2

1832

8701

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.7

206.3

493

1088

M01AH03

ATC

valdecoxib; oral

3.1

205.8

908

3061

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.4

205.8

271

331

M25.2

ICD-10 Finland

Flail joint

10.6

205.1

226

218

J01DB01

ATC

cefalexin; oral

2.1

205.1

9601

80134

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

203.8

2174

11180

R01AD09

ATC

mometasone; nasal

1.8

199.4

5213

36150

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

197.4

189

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.1

194.9

552

1389

M01AX01

ATC

nabumetone; oral

3.8

194.2

624

1718

NBF15

NOMESCO Finland

Humeroscapular synovectomy, arthroscopic

40.7

193.6

117

N06AX11

ATC

mirtazapine; oral

1.8

192.9

3870

24707

M24.2

ICD-10 Finland

Disorder of ligament

7.9

192.5

266

344

M75

ICD-10 Finland

Shoulder lesions

3.7

192.3

644

1824

X58

ICD-10 Finland

Exposure to other specified factors

2.3

191.8

1642

7703

NBL68

NOMESCO Finland

Transpostion, tenodesis, shortening or lengthening of tendon of shoulder or upper arm

11.3

191.2

201

181

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.2

188.6

799

2626

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

188.5

1347

5828

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.5

188.4

478

1106

M01AB08

ATC

etodolac; oral

2.8

187.4

994

3708

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

6.8

186.7

294

440

XA402

NOMESCO Finland

ENMG

5.2

185.9

391

774

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

185.9

5396

38320

M01AC01

ATC

piroxicam; systemic, rectal

2.3

185.8

1708

8248

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.1

184.7

829

2818

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

181.3

5302

37642

UJF32

NOMESCO Finland

Coloscopy

1.9

180.2

3112

18873

H02AB04

ATC

methylprednisolone; systemic

2.2

179.8

1782

8863

J01FA10

ATC

azithromycin; systemic

1.7

179.5

6435

48316

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

4.5

177.1

441

1005

J01DA01

ATC

[U] cefalexin

1.7

176.0

6960

53577

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.2

176.0

488

1208

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.3

174.7

1509

7088

NB1DG

NOMESCO Finland

Shoulder and humerus very extensive MRI examination with high intensity magnet

12.0

174.2

176

149

A01

ICPC

Pain general/multiple sites

2.7

174.2

996

3860

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

173.9

4687

32401

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.4

173.2

667

2066

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

173.1

2951

17787

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

172.7

1777

8960

R52.9

ICD-10 Finland

Pain, unspecified

2.6

172.7

1121

4627

M54.3

ICD-10 Finland

Sciatica

3.1

172.2

770

2609

A02BC01

ATC

omeprazole; systemic

1.9

171.5

3011

18310

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

169.8

8125

65675

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.4

169.5

652

2018

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.5

167.6

1134

4771

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

167.4

3088

19048

M77.4

ICD-10 Finland

Metatarsalgia

3.4

166.8

639

1972

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

166.3

4880

34416

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.3

166.0

439

1048

NBE15

NOMESCO Finland

Incision or suture of capsule of joint of shoulder, arthroscopic

28.0

164.7

111

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.9

164.6

498

1313

G47.3

ICD-10 Finland

Sleep apnoea

1.9

162.0

2875

17493

M19.9

ICD-10 Finland

Arthrosis, unspecified

3.5

161.8

577

1701

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

161.4

1208

5320

R42

ICD-10 Finland

Dizziness and giddiness

1.9

161.4

2415

13905

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

161.2

3244

20506

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

161.2

1237

5509

A02BA02

ATC

ranitidine; systemic

2.0

160.4

2141

11854

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

160.3

2079

11396

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.6

158.5

995

4035

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

157.9

5833

43544

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

13.5

157.7

148

111

M54.1

ICD-10 Finland

Radiculopathy

3.7

157.1

526

1487

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.7

156.7

898

3479

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.8

156.5

872

3329

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.6

155.2

381

858

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

9.1

154.9

190

212

N02BF02

ATC

pregabalin; oral

3.0

154.8

707

2422

SFA10

NOMESCO Finland

One-surface restoration

1.7

153.8

6121

46460

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

153.3

1543

7687

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

151.9

2546

15172

M22.4

ICD-10 Finland

Chondromalacia patellae

4.2

150.6

406

983

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

150.1

1171

5246

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

149.9

2012

11136

M76.6

ICD-10 Finland

Achilles tendinitis

3.5

148.5

531

1567

M19.8

ICD-10 Finland

Other specified arthrosis

3.5

148.2

533

1579

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

147.9

3608

23992

J01FA09

ATC

clarithromycin; systemic

1.7

146.7

3567

23688

Z50.1

ICD-10 Finland

Other physical therapy

3.0

145.9

668

2291

NHM10

NOMESCO Finland

Fasciotomy of ankle or foot

45.1

143.9

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

143.8

7244

57948

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.5

143.4

512

1509

SPAT1263

SPAT

Sampling

1.7

143.2

4388

30953

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

5.1

142.7

304

608

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

142.0

1044

4551

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

141.5

6283

48605

J01FA06

ATC

roxithromycin; oral

1.7

141.2

4401

31152

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

34.5

140.8

J01CA04

ATC

amoxicillin; systemic

1.8

140.3

9094

77544

J01FF01

ATC

clindamycin; systemic

1.8

140.0

3023

19369

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

138.6

7908

64991

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.0

138.0

398

1013

L86

ICPC

Back syndrome with radiating pain

2.8

137.7

716

2632

Z01.2

ICD-10 Finland

Dental examination

1.6

135.2

4943

36303

1220

FHL

Arthroscopy

3.3

133.5

515

1594

L02

ICPC

Back symptom/complaint

2.4

133.3

1049

4707

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

7.2

133.3

199

281

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

132.3

994

4370

N02AA05

ATC

oxycodone; systemic

1.9

131.8

1873

10526

N06AA10

ATC

nortriptyline; systemic

4.9

131.0

292

607

SFA20

NOMESCO Finland

Two-surface restoration

1.6

130.3

6551

51774

NBK02

NOMESCO Finland

Excision of fragment of bone of shoulder or upper arm, clavicle

56.5

129.4

R01AD08

ATC

fluticasone; nasal

1.7

128.5

3166

20952

K30

ICD-10 Finland

Functional dyspepsia

2.2

127.6

1254

6164

R05

ICD-10 Finland

Cough

1.8

127.6

2334

14192

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

127.2

2522

15703

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.9

126.4

617

2190

NBE25

NOMESCO Finland

Suture or reinsertion of ligament of shoulder, arthroscopic

18.7

126.4

100

N06AX16

ATC

venlafaxine; oral

2.0

126.0

1515

8027

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

125.1

942

4142

M70.7

ICD-10 Finland

Other bursitis of hip

4.5

124.8

307

692

R07.3

ICD-10 Finland

Other chest pain

2.2

124.4

1104

5207

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.1

124.2

1310

6613

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

123.3

734

2890

M01AC02

ATC

tenoxicam; systemic, rectal

2.9

122.6

613

2204

S83.2

ICD-10 Finland

Tear of meniscus, current

2.4

122.0

877

3776

ZA1.0

ICD-10 Finland

Shoulder region

4.2

121.2

328

796

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

120.3

4109

29441

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

119.9

4336

31491

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

5.9

119.8

217

374

K02.1

ICD-10 Finland

Caries of dentine

1.6

119.6

6335

50235

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

119.2

1027

4782

A02BC04

ATC

rabeprazole; oral

2.2

117.9

1026

4795

R01AD58

ATC

fluticasone, combinations; nasal

1.7

117.6

2542

16170

M54

ICD-10 Finland

Dorsalgia

2.1

117.0

1275

6508

L11

ICPC

Wrist symptom/complaint

2.4

116.2

900

4003

R03DC03

ATC

montelukast; oral

1.9

116.1

1755

10029

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

116.0

2697

17492

L16

ICPC

Ankle symptom/complaint

2.2

115.9

1139

5589

J01DA09

ATC

[U] cefadroxil

1.7

115.8

2843

18709

N04BC05

ATC

pramipexole; oral

2.4

115.3

856

3737

M76.0

ICD-10 Finland

Gluteal tendinitis

5.1

115.2

242

478

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

5.7

114.8

216

386

M09AX01

ATC

hyaluronic acid; parenteral

3.0

114.6

528

1814

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

5.2

114.5

240

473

P01AB01

ATC

metronidazole; oral, rectal

1.6

114.0

4338

31779

R05

ICPC

Cough

1.7

114.0

2488

15851

J02AC01

ATC

fluconazole; systemic

1.6

113.9

4125

29871

NG2AA

NOMESCO Finland

Patella X-ray examination

3.7

113.9

376

1051

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.0

112.2

1269

6561

SPAT1301

SPAT

No procedures

1.6

111.9

3165

21569

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

4.5

111.3

278

634

M01AE52

ATC

naproxen and esomeprazole; oral

3.3

110.7

436

1365

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

110.7

1178

5953

Z3226

NOMESCO Finland

Physiotherapist

1.8

110.7

1870

11049

9476

FHL

Splitting of fascia or aponeurosis

14.7

110.0

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

39.6

109.9

M15

ICD-10 Finland

Polyarthrosis

2.8

109.6

575

2120

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.1

109.4

464

1519

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

109.0

2495

16075

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

5.4

108.7

214

399

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

24.2

108.4

M02AA15

ATC

diclofenac; topical

2.3

108.4

866

3901

N05CF01

ATC

zopiclone; oral

1.6

108.2

3377

23540

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

108.1

4558

34061

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

4.7

108.0

255

556

S46.1

ICD-10 Finland

Injury of muscle and tendon of long head of biceps

5.8

107.5

196

340

L28

ICPC

Limited function/disability (L)

1.9

107.4

1659

9527

J01MA02

ATC

ciprofloxacin; systemic

1.6

107.2

4172

30604

R03BA05

ATC

fluticasone; inhalant

1.8

107.2

1876

11193

C10AX09

ATC

ezetimibe; oral

1.8

106.9

1874

11186

NCL22

NOMESCO Finland

Myotomy or tenotomy of elbow or forearm

533.0

106.9

106

NBL99

NOMESCO Finland

Other operation on muscle or tendon of shoulder or upper arm

25.7

106.5

R06AE07

ATC

cetirizine; oral

1.5

106.2

4583

34387

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.8

105.9

332

896

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

105.5

2019

12364

R74

ICPC

Upper respiratory infection acute

1.6

104.6

2949

20020

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

104.5

4012

29298

N02AJ13

ATC

tramadol and paracetamol; systemic

4.1

104.4

295

739

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

3.0

103.9

492

1715

K07.60

ICD-10 Finland

Snapping jaw

2.9

103.8

513

1831

M43.1

ICD-10 Finland

Spondylolisthesis

2.9

103.4

490

1709

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

5.2

102.3

211

410

AA1AD

NOMESCO Finland

CT of head and brain

1.6

102.3

2790

18768

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

101.5

1365

7484

Z00.0

ICD-10 Finland

General medical examination

1.8

101.0

1980

12192

N02AC04

ATC

dextropropoxyphene; oral

3.4

100.5

375

1135

M13.9

ICD-10 Finland

Arthritis, unspecified

2.3

100.4

775

3436

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

100.4

4920

37802

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

99.1

1253

6724

M89.0

ICD-10 Finland

Algoneurodystrophy

8.7

98.9

125

145

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.5

98.1

680

2873

ZXD20

NOMESCO Finland

Day surgery

1.9

97.7

1351

7471

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

97.3

2990

20666

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

96.3

916

4425

C10AA07

ATC

rosuvastatin; oral

1.5

96.1

3757

27421

M23.8

ICD-10 Finland

Other internal derangements of knee

3.0

96.0

439

1500

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.1

95.9

412

1358

R01AD12

ATC

fluticasone furoate; nasal

1.6

95.8

3204

22572

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

9.1

95.4

116

128

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

95.3

1125

5890

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

95.0

593

2384

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

4.1

94.5

261

643

WX320

NOMESCO Finland

Spinalanesthesy

1.6

94.2

2486

16534

SPAT1310

SPAT

Counselling related to known health issue

1.6

94.0

3217

22766

R4110, ,

SPAT

2.1

93.6

962

4786

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

93.5

2906

20106

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

93.2

2833

19498

SFA30

NOMESCO Finland

Three-surface restoration

1.5

92.4

4830

37401

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

92.0

2212

14356

R02

ICPC

Shortness of breath/dyspnoea

1.9

91.7

1277

7068

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

91.7

2185

14147

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

91.7

2992

20923

L29

ICPC

Musculoskeletal sympt/complt other

2.2

91.6

878

4252

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.2

91.4

841

4007

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.1

91.1

254

630

S80.0

ICD-10 Finland

Contusion of knee

2.3

90.6

734

3320

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

90.5

1955

12328

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

90.4

461

1672

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

5.4

90.4

180

339

D82

ICPC

Teeth/gum disease

1.5

90.2

3801

28105

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

89.8

1593

9502

M01AB51

ATC

indometacin, combinations; oral, rectal

3.5

89.1

310

897

A03FA02

ATC

cisapride; oral, rectal

2.2

88.8

765

3548

M19.2

ICD-10 Finland

Other secondary arthrosis

5.4

88.8

176

330

UKC02

NOMESCO Finland

Cystoscopy

1.8

88.1

1634

9869

R51

ICD-10 Finland

Headache

2.6

87.5

537

2141

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.5

87.2

309

905

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.7

87.1

201

430

C10AA05

ATC

atorvastatin; oral

1.5

87.1

4684

36344

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.2

87.0

754

3505

R96

ICPC

Asthma

2.0

86.8

990

5113

R13

ICD-10 Finland

Dysphagia

2.3

86.8

726

3326

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

4.2

86.6

234

567

WX290

NOMESCO Finland

Other blockage of nerve

1.5

86.5

4723

36739

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.0

86.0

396

1358

C10AA01

ATC

simvastatin; oral

1.5

85.9

4473

34457

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

85.5

1193

6599

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

85.3

375

1253

R06AX27

ATC

desloratadine; oral

1.6

85.0

2808

19634

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

84.8

2490

16939

C07AB07

ATC

bisoprolol; oral

1.5

83.9

5107

40499

R20.2

ICD-10 Finland

Paraesthesia of skin

2.3

83.9

701

3209

N05CF02

ATC

zolpidem; oral

1.7

83.8

1863

11814

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3.4

83.6

304

905

NBK92

NOMESCO Finland

Other operation on bone of shoulder or upper arm, clavicle

21.5

83.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

82.7

2447

16660

N01

ICPC

Headache

2.1

82.5

841

4166

S22.3

ICD-10 Finland

Fracture of rib

2.2

82.3

748

3544

P01BA02

ATC

hydroxychloroquine; oral

2.1

82.0

833

4120

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

82.0

618

2707

C01DA14

ATC

isosorbide mononitrate; oral

1.8

82.0

1265

7222

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

81.9

465

1783

M54.8

ICD-10 Finland

Other dorsalgia

2.7

81.9

454

1720

G50.1

ICD-10 Finland

Atypical facial pain

4.3

81.9

215

510

M66.0

ICD-10 Finland

Rupture of popliteal cyst

9.6

81.8

101

G56.4

ICD-10 Finland

Causalgia

13.7

81.7

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.0

81.7

233

588

ACC53

NOMESCO Finland

Release of ulnar nerve

4.7

81.3

188

403

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

8.5

81.0

104

123

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

80.9

730

3448

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

80.9

2329

15746

R03BA08

ATC

ciclesonide; inhalant

2.0

80.8

936

4856

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.8

80.7

412

1495

R03BA02

ATC

budesonide; inhalant

1.7

80.6

1778

11241

UJD02

NOMESCO Finland

Gastroscopy

2.5

80.5

531

2190

XF402

NOMESCO Finland

ECG with work load test

1.9

80.4

1144

6364

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

80.3

825

4097

7263A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of elbow region[EPICONDYLITIS LATERALIS HUMERI]

+∞

80.3

SPAT1202

SPAT

Intra-articular injection

3.1

80.1

350

1165

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.9

79.8

109

139

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.9

79.7

1071

5847

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

6.6

79.5

127

193

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

79.2

944

4947

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

78.4

1166

6575

K10.3

ICD-10 Finland

Alveolitis of jaws

2.6

78.1

488

1961

NBM20

NOMESCO Finland

Excision of bursa of shoulder or upper arm

46.2

78.0

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

77.8

310

977

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

4.3

77.8

201

471

M01AB16

ATC

aceclofenac; oral

2.8

77.7

389

1397

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.1

77.5

216

536

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

77.1

254

709

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

3.9

76.8

230

601

D01

ICPC

Abdominal pain/cramps general

1.9

76.8

1052

5776

9481

FHL

Detachment or severance of a muscle or tendon

21.2

76.1

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

75.9

822

4160

J01FA15

ATC

telithromycin; oral

1.9

75.3

1098

6149

RF210, ,

NOMESCO Finland

3.2

74.9

311

1005

KMAK, ,

NOMESCO Finland

1.4

74.8

5264

42566

L10

ICPC

Elbow symptom/complaint

2.4

74.8

537

2301

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.4

74.4

529

2257

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

74.2

733

3583

EB1VA, ,

NOMESCO Finland

1.8

73.8

1363

8192

C05AA08

ATC

fluocortolone; rectal, topical

1.7

73.6

1475

9069

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

73.4

814

4154

M20.2

ICD-10 Finland

Hallux rigidus

2.8

73.3

381

1395

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

73.3

490

2032

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

73.3

739

3641

A02BA04

ATC

nizatidine; systemic

2.1

73.0

754

3749

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.0

72.8

865

4524

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.6

72.7

247

704

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.3

72.6

548

2400

N03AE01

ATC

clonazepam; systemic

2.3

72.6

588

2655

R09

ICPC

Sinus symptom/complaint

2.1

72.0

754

3767

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.2

72.0

624

2897

M35.7

ICD-10 Finland

Hypermobility syndrome

6.1

71.9

125

207

SPAT1216

SPAT

Assessment of functional ability

1.7

71.6

1401

8554

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.0

71.5

204

515

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

71.4

661

3150

H01

ICPC

Ear pain/earache

1.9

71.3

1014

5631

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.0

70.9

316

1064

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

70.9

776

3941

R03AC03

ATC

terbutaline; inhalant

1.7

70.8

1351

8189

M01AE51

ATC

ibuprofen, combinations; systemic

4.1

70.6

197

489

J01EA01

ATC

trimethoprim; systemic

1.5

70.3

2378

16607

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

7.6

70.2

131

NF1DA

NOMESCO Finland

X-ray of hips

3.4

70.2

254

754

M01AB01

ATC

indometacin; systemic, rectal

2.1

69.9

745

3745

J20

ICD-10 Finland

Acute bronchitis

1.9

69.8

1025

5747

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

69.8

585

2678

SPAT1312

SPAT

General health counselling

1.5

69.8

3004

22064

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

69.8

431

1722

WX702

NOMESCO Finland

Supraglottic ventilation device

2.2

69.8

616

2881

S29

ICPC

Skin symptom/complaint other

1.6

69.5

1856

12273

R75

ICPC

Sinusitis acute/chronic

2.4

69.2

473

1982

SPAT1058

SPAT

PEF monitoring instruction

2.0

69.1

840

4425

G04BD12

ATC

mirabegron; oral

1.8

68.9

1169

6850

NB1CM

NOMESCO Finland

Shoulder and humerus extensive MRI examination with 3 Tesla magnet

17.6

68.8

R52.1

ICD-10 Finland

Chronic intractable pain

6.4

68.7

113

177

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

68.6

3551

27014

G04CA01

ATC

alfuzosin; oral

1.7

68.6

1323

8040

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

68.3

2912

21329

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.2

68.2

609

2861

W19

ICD-10 Finland

Unspecified fall

1.9

68.1

924

5050

NB1AD

NOMESCO Finland

Shoulder CT examination

3.9

68.1

205

538

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

68.0

1504

9482

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

67.8

B01AB05

ATC

enoxaparin; parenteral

1.5

67.5

3194

23871

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.8

67.0

347

1268

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

67.0

1095

6342

J37.0

ICD-10 Finland

Chronic laryngitis

2.7

66.9

372

1411

SPAT1211

SPAT

Application of soft bandage

2.0

66.9

821

4339

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.5

66.8

234

680

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

66.8

1082

6251

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

66.7

900

4908

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

66.4

841

4491

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

4.2

66.4

178

429

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

5.2

66.3

137

267

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

66.3

504

2214

N05BA04

ATC

oxazepam; oral

1.5

66.3

2492

17773

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

66.0

3780

29252

DAX08

NOMESCO Finland

Fitting of hearing aid

2.2

65.9

557

2558

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

65.8

4248

33581

K08.80

ICD-10 Finland

Toothache NOS

1.9

65.8

865

4678

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.3

65.7

534

2413

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

65.4

1673

10933

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

5.3

65.1

132

253

L14

ICPC

Leg/thigh symptom/complaint

2.0

65.0

712

3613

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

65.0

593

2808

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

65.0

1194

7151

SDA03

NOMESCO Finland

Periodontal treatment

1.4

65.0

4193

33119

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

64.8

1303

8001

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

64.8

683

3418

NB1BG, ,

SPAT

3.2

64.6

258

814

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

64.6

1026

5888

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

64.6

1404

8802

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.0

64.6

293

996

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

64.5

1350

8379

D07AC01

ATC

betamethasone; topical

1.4

64.4

3701

28627

R53

ICD-10 Finland

Malaise and fatigue

1.6

64.3

2012

13777

WX204

NOMESCO Finland

Axillary plexus blockaced

2.8

64.3

320

1145

WX704

NOMESCO Finland

Intubation

1.9

64.1

877

4803

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.2

63.9

558

2596

-, ,

ICD-10 Finland

3.2

63.9

263

845

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

63.9

1416

8923

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

63.8

629

3069

A10AA01, ,

ATC

3.2

63.3

254

804

E0000UV, ,

ATC

1.4

63.2

4088

32259

XQ800

NOMESCO Finland

Prick test

2.0

63.2

694

3525

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

63.1

2562

18534

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

62.9

3295

25035

SGA01

NOMESCO Finland

Emergency treatment

1.6

62.8

1621

10607

7177A

ICD-9 Finland

Internal derangement of knee, Chondromalacia of patella

4.3

62.5

164

389

J05AB01

ATC

aciclovir; systemic

1.5

62.2

2127

14841

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

62.2

2551

18485

L90

ICPC

Osteoarthrosis of knee

2.0

62.1

692

3532

R21

ICPC

Throat symptom/complaint

1.6

61.7

1645

10847

E66.8

ICD-10 Finland

Other obesity

2.2

61.7

550

2581

R03BA01

ATC

beclometasone; inhalant

1.7

61.7

1361

8561

A10AB04

ATC

insulin lispro; parenteral

2.9

61.4

303

1079

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

2.7

61.3

344

1311

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

61.2

686

3509

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.2

61.0

515

2363

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

60.9

639

3192

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

60.8

869

4825

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

60.8

408

1695

D19

ICPC

Teeth/gum symptom/complaint

1.5

60.6

2770

20486

R12

ICD-10 Finland

Heartburn

1.9

60.5

793

4280

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

60.4

1397

8889

NDF25

NOMESCO Finland

Operation for osteochondritis of joint of wrist, arthroscopic

7.6

60.1

113

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

59.9

431

1847

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.8

59.8

312

1145

B01AF01

ATC

rivaroxaban; oral

1.7

59.7

1271

7916

M71.1

ICD-10 Finland

Other infective bursitis

12.7

59.7

SFA00

NOMESCO Finland

Small restoration

1.6

59.5

1399

8937

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

59.4

3194

24334

J45

ICD-10 Finland

Asthma

1.8

59.2

987

5743

R06.5

ICD-10 Finland

Mouth breathing

1.8

59.0

967

5598

TQW40, ,

SPAT

1.9

58.8

777

4205

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

58.7

1221

7555

L05

ICPC

Flank/axilla symptom/complaint

2.1

58.5

579

2829

A01AB09

ATC

miconazole; local oral

1.9

58.4

797

4358

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.7

58.3

136

294

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.0

58.2

168

428

S06.0

ICD-10 Finland

Concussion

1.8

58.2

932

5357

D07AC13

ATC

mometasone; topical

1.4

58.1

2927

22018

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

57.9

598

2969

C03CA01

ATC

furosemide; systemic

1.5

57.6

2489

18183

Z54.0

ICD-10 Finland

Convalescence following surgery

3.7

57.4

183

500

T89

ICPC

Diabetes insulin dependent

2.5

57.2

375

1540

A10AA02, ,

ATC

2.8

57.2

286

1026

SPAT1229

SPAT

Assessment of need for aid

2.0

57.1

682

3567

R51.81

ICD-10 Finland

Facial pain NOS

3.1

57.0

242

792

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

5.7

56.7

105

185

XG410

NOMESCO Finland

Flow-volume spirometry

2.4

56.7

412

1773

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.0

56.6

645

3318

T92.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of upper limb

5.6

56.6

108

196

SPAT1260

SPAT

Consultation of another employee

1.6

56.5

1647

11067

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.3

56.5

213

649

73398

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Alii definiti

+∞

56.3

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

56.2

757

4121

OAA65, ,

SPAT

1.6

56.2

1320

8425

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

56.0

3661

28793

M53.2

ICD-10 Finland

Spinal instabilities

5.4

56.0

110

205

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.9

56.0

813

4533

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

55.9

1909

13281

M66.4

ICD-10 Finland

Spontaneous rupture of other tendons

21.1

55.8

A10AB01

ATC

insulin (human); parenteral

2.7

55.8

301

1124

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

55.8

522

2496

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

55.7

467

2136

OAB93, ,

SPAT

2.2

55.7

494

2312

L18

ICPC

Muscle pain

2.4

55.6

388

1640

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

9.0

55.4

WX400

NOMESCO Finland

Inhalation anesthesy

2.3

55.3

410

1781

R06AX22

ATC

ebastine; oral

1.6

55.3

1678

11377

J34.2

ICD-10 Finland

Deviated nasal septum

2.1

55.2

566

2802

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

54.9

768

4230

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.4

54.9

389

1656

NGE10

NOMESCO Finland

Incision or suture of capsule of knee joint

5.4

54.9

107

198

R60.0

ICD-10 Finland

Localized oedema

1.7

54.8

1058

6410

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.1

54.8

550

2701

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

54.6

1210

7606

L84

ICPC

Back syndrome without radiat pain

2.3

54.5

440

1981

N05AH04

ATC

quetiapine; oral

1.6

54.5

1539

10260

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

54.4

415

1825

L20

ICPC

Joint symptom/complaint NOS

2.5

54.3

355

1457

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.5

54.2

186

534

A29

ICPC

General symptom/complaint other

1.7

54.1

1158

7213

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2626

12771

2.36

293.09

1.3

1.2

10.53

13.85

u/ml

1.57

946

5016

(3013707) Erythrocyte sedimentation rate by Westergren method

8883

68709

2.23

288.84

4.8

3.7

11.13

12.25

mm/h

13.15

8331

63389

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2683

13695

2.25

263.70

1.3

1.2

27.44

36.98

iu/ml

3.26

856

4527

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2346

12080

2.18

221.06

5.0

4.5

32.08

32.05

0.04

1698

8183

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4338

28395

1.84

201.52

2.7

2.5

55.72

66.82

u/l

2.77

4023

26170

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4100

26619

1.83

193.73

2.2

2.0

196.84

223.25

u/l

0.86

3868

24906

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4925

33972

1.78

188.56

3.7

3.1

33.36

61.75

ng/l

2.39

3442

23041

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10754

95768

2.60

169.05

15.6

12.8

21.21

25.00

mg/l

27.83

8790

74159

(3037467) Urinalysis macro (dipstick) panel - Urine

7824

62621

1.76

168.49

4.7

3.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

6970

54286

1.71

162.82

4.9

4.7

6.75

6.76

mmol/l

0.11

6595

50912

(3019225) pH of Specimen

1753

9063

2.10

158.53

3.7

4.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8834

74022

1.80

153.51

7.7

75.80

79.23

u/l

13.46

8365

69765

(3031040) Bacteria [#/volume] in Urine by Automated count

7375

58934

1.69

150.43

4.7

3.9

491.35

1502.46

e6/l

1.72

867

(3013512) EKG study

4016

27666

1.69

143.53

4.1

3.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2826

17743

1.78

140.46

1.8

1.7

0.99

1.32

mg/l

7.54

2160

13684

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5684

43125

1.62

136.58

2.7

2.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9982

88069

1.93

131.71

5.4

4.4

1.83

2.25

mu/l

5.86

9185

80381

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10253

91374

2.02

130.01

6.6

5.5

40.40

39.74

mmol/mol

10.23

9573

84406

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6286

49227

1.60

129.68

5.8

6.8

10.55

11.68

umol/l

13.90

5982

46880

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4959

36822

1.60

127.11

2.1

1.9

99.03

95.95

pmol/l

3.86

2587

19135

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2020

11793

1.86

125.85

7.1

6.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8469

71695

1.66

123.60

4.4

3.8

14.86

14.78

pmol/l

2.33

7747

65177

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5462

41798

1.58

121.06

6.0

6.1

1.21

mmol/l

2.37

4908

38174

(40761535) Cells panel - Urine sediment

1358

7112

2.03

116.11

3.5

3.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3258

22222

1.65

115.47

2.4

2.3

—

(3019150) Specific gravity of Urine by Refractometry

2829

18645

1.68

114.34

4.5

3.7

1.04

1.02

kg/l

0.52

393

2816

(3022217) INR in Platelet poor plasma by Coagulation assay

5562

43094

1.56

114.26

12.9

13.1

1.22

1.25

inr

1.34

1291

12288

(3026493) Urate [Moles/volume] in Serum or Plasma

3518

24545

1.62

113.41

2.5

2.6

2968.92

4688.25

umol/l

2.30

3095

21648

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3575

25061

1.62

112.92

3.0

2.8

829.94

1231.92

ng/l

13.08

3010

21513

(3019550) Sodium [Moles/volume] in Serum or Plasma

11004

101704

2.49

112.69

17.8

14.9

139.90

139.75

mmol/l

9.10

10813

99093

(3023103) Potassium [Moles/volume] in Serum or Plasma

11028

102066

2.52

111.85

17.9

15.0

4.00

3.97

mmol/l

11.81

10816

99266

(3013115) Eosinophils [#/volume] in Blood

5987

47443

1.54

109.02

5.7

6.1

0.20

0.19

e9/l

1.51

5384

41276

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5835

46036

1.54

108.02

6.8

1.22

1.21

mmol/l

2.61

5159

38943

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

781

3437

2.36

102.98

3.2

3.7

24.86

24.87

mmol/l

0.03

726

3190

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2688

17927

1.65

101.93

1.3

1.2

1.56

1.90

u/ml

0.79

670

4795

(3006315) Basophils [#/volume] in Blood

5775

45938

1.51

99.58

5.6

5.8

0.04

e9/l

0.71

5160

39407

(40768797) Stomach Pathology biopsy report

2001

12440

1.73

98.40

1.3

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

5892

47136

1.51

98.36

5.6

5.9

1.95

1.93

e9/l

0.19

5356

41333

(3001604) Monocytes [#/volume] in Blood

5755

45835

1.51

98.05

5.6

5.8

0.58

0.59

e9/l

4.88

5160

39345

(3037522) Nuclear Ab [Titer] in Serum

1842

11205

1.76

97.74

1.4

1.3

567.10

532.18

titre

0.32

435

2341

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10738

99086

2.07

96.60

5.2

4.4

4.69

4.74

mmol/l

4.73

10033

92001

(3011397) Hemoglobin [Presence] in Urine by Test strip

2964

20501

1.60

95.93

4.2

3.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10514

96362

1.94

95.77

5.3

4.5

6.06

5.95

mmol/l

11.03

9704

88047

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10408

95136

1.88

94.75

4.7

3.9

1.36

1.31

mmol/l

9.46

9655

87160

(40760892) CBC W Ordered Manual Differential panel - Blood

5437

43000

1.50

94.52

5.9

6.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10673

98414

2.01

94.02

5.2

4.4

1.46

1.47

mmol/l

3.45

9944

90850

(3022313) Gas panel - Capillary blood

839

3976

2.20

92.48

3.2

3.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10851

100823

2.12

90.86

5.8

4.9

2.76

2.81

mmol/l

6.46

10099

93141

(3044640) Blood type and Crossmatch panel - Blood

3925

29190

1.52

90.81

2.5

2.4

—

(4200892) Spirometry reversibility

1229

6806

1.90

87.94

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11176

105306

2.52

86.83

11.9

10.1

27.23

27.02

u/l

0.53

10854

101547

(3013650) Neutrophils [#/volume] in Blood by Automated count

6499

53837

1.47

85.93

8.0

9.8

4.03

4.06

e9/l

0.45

5831

46777

(3048689) Calprotectin [Mass/mass] in Stool

1603

9753

1.75

83.91

2.1

2.3

124.95

142.66

ug/g

1.27

1211

7732

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7481

64193

1.46

78.82

3.6

3.0

50.14

51.03

u/l

0.41

7017

59741

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1054

5745

1.92

78.75

2.4

2.3

20.63

25.32

au/ml

0.88

486

(3017732) Neutrophils [#/volume] in Blood

1127

6282

1.88

78.60

3.0

2.9

5.04

4.84

e9/l

0.17

884

5049

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

972

5243

1.93

74.78

1.3

49.71

51.64

au/ml

0.09

327

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4704

37279

1.44

74.58

2.4

2.2

79.02

77.79

nmol/l

2.24

4222

33572

(3019309) Folate [Moles/volume] in Red Blood Cells

2270

15515

1.58

74.44

1.7

1100.54

1159.49

nmol/l

2.59

1745

11707

(3021960) Folate [Moles/volume] in Serum or Plasma

2781

19924

1.52

73.55

1.5

21.05

20.35

nmol/l

1.55

2321

16988

(40761511) CBC panel - Blood by Automated count

10820

101450

1.94

72.53

15.2

12.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1001

5513

1.89

72.21

3.2

3.5

5.16

5.13

kpa

0.66

942

5243

(3004616) Nuclear Ab [Presence] in Serum

295

945

3.18

72.05

1.3

1.2

—

(3009343) pH of Capillary blood

989

5452

1.89

71.10

3.2

3.5

7.42

0.20

723

(3000475) Leukocytes [#/volume] in Synovial fluid

422

1670

2.58

69.67

1.7

1.6

13428.52

14733.17

e6/l

0.20

320

1218

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2014

13619

1.58

68.51

1.9

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2294

15991

1.54

68.13

1.4

1.5

2.39

2.52

g/l

2.22

1348

9745

(3009542) Hematocrit [Volume Fraction] of Blood

11377

109061

2.87

67.98

23.4

19.2

40.64

40.67

0.11

10600

102041

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

951

5255

1.88

67.74

3.1

3.4

1.45

1.75

mmol/l

1.93

727

3919

(3035941) MCH [Entitic mass]

11382

109227

2.85

66.08

23.3

19.0

30.44

30.38

2.84

11271

107555

(3024731) MCV [Entitic volume]

11382

109248

2.85

65.66

23.4

19.0

91.27

91.17

1.71

11271

107570

(3010813) Leukocytes [#/volume] in Blood

11382

109252

2.84

65.58

23.5

19.1

6.62

6.61

e9/l

0.32

11179

105641

(3026361) Erythrocytes [#/volume] in Blood

11382

109259

2.84

65.44

23.5

19.1

4.52

e12/l

0.33

11182

105676

(3000963) Hemoglobin [Mass/volume] in Blood

11383

109292

2.84

65.06

23.6

19.2

136.86

136.60

g/l

1.15

11272

107626

(3007461) Platelets [#/volume] in Blood

11374

109163

2.80

65.05

23.5

19.1

250.77

250.40

e9/l

0.25

11196

105955

(3009508) Creatinine [Moles/volume] in Urine

3892

30405

1.42

63.94

3.4

3.1

7.84

7.71

mmol/l

1.03

3291

25615

(3024561) Albumin [Mass/volume] in Serum or Plasma

4941

40288

1.39

63.00

4.7

5.0

36.10

35.47

g/l

13.80

4628

37614

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2794

20573

1.47

62.92

2.4

2.1

2.86

2.97

mg/l

1.73

2410

17483

(3012516) Albumin [Mass/volume] in Urine

3752

29281

1.42

61.37

3.5

3.2

456.55

360.33

mg/l

0.54

2373

18367

(3008898) HLA-B27 [Presence]

488

2191

2.28

60.93

1.1

1.0

—

(3015736) pH of Urine

4409

35433

1.39

60.53

3.8

3.1

5.75

5.81

0.54

317

2875

(3018010) Neutrophils/100 leukocytes in Blood

5295

43893

1.38

60.03

5.8

5.9

56.39

57.22

6.15

4954

41169

(3020682) Albumin/Creatinine [Ratio] in Urine

3906

30831

1.40

59.31

4.0

3.8

7.59

8.02

mg/mmol

0.23

2445

19286

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

421

1798

2.39

58.98

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4492

36389

1.38

58.01

3.0

2.7

130.81

151.73

ug/l

5.71

4161

33732

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1211

7504

1.69

57.89

2.3

2.2

6.17

8.80

ug/l

3.96

1050

6647

(3002030) Lymphocytes/100 leukocytes in Blood

5350

44591

1.37

57.80

6.0

6.1

28.80

27.80

9.74

5019

41867

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

288

1057

2.77

55.19

1.4

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

5363

44919

1.36

55.17

4.0

3.3

0.01

0.00

estimate

0.11

554

7966

(3042936) Bacteria identified in Isolate by Culture

1771

12156

1.54

55.15

2.1

2.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

288

1058

2.77

55.09

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

294

1092

2.74

55.07

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

290

1071

2.75

54.92

1.4

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6450

55609

1.36

54.88

2.8

2.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

289

1072

2.74

54.27

1.4

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

889

5157

1.78

53.67

1.3

144.84

246.61

u/ml

6.03

832

4757

(3025468) Yersinia sp identified in Specimen by Organism specific culture

285

1056

2.74

53.64

1.4

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

5195

43455

1.35

53.15

6.3

8.44

8.67

5.80

4860

40711

(36660697) Celiac disease serology panel - Serum

1055

6455

1.70

52.65

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1485

9896

1.57

52.56

1.9

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

5161

43188

1.35

52.39

5.8

6.0

2.94

2.88

1.24

4809

40399

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1842

12897

1.51

51.97

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

491

2372

2.12

51.04

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

668

3604

1.91

50.86

2.0

1.9

—

(3038026) Centromere Ab [Units/volume] in Serum

202

642

3.18

50.06

1.2

49.08

60.93

u/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

427

1972

2.21

49.75

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

5248

44264

1.34

49.46

4.0

3.3

0.00

estimate

3.19

609

8645

(3021601) Nitrite [Presence] in Urine by Test strip

5259

44413

1.34

48.95

5.2

4.4

0.00

estimate

1.84

567

8223

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

196

628

3.16

47.94

1.2

52.92

44.59

u/ml

0.14

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

434

2048

2.16

47.91

1.3

5.05

8.66

u/ml

1.28

333

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

430

2029

2.16

47.47

1.3

1.2

7.72

3.23

u/ml

0.49

212

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2315

17250

1.43

46.77

4.1

3.4

334.98

637.86

ng/l

2.65

1734

13503

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

457

2231

2.09

46.19

1.2

30.32

47.73

u/ml

0.67

142

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

188

603

3.15

45.91

1.2

6.50

8.79

u/ml

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

607

3281

1.90

45.88

1.8

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

370

1669

2.26

45.65

1.2

2.80

23.02

u/ml

—

(3022096) Basophils/100 leukocytes in Blood

4957

41781

1.32

45.57

5.9

6.1

0.71

0.69

1.74

4605

38979

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1181

7705

1.59

45.38

2.9

2.6

69.46

66.19

ml/min/173m2

2.24

466

2885

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

271

1070

2.57

44.97

2.1

1.9

28.67

28.07

mg/l

0.05

284

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

373

1700

2.23

44.89

1.2

1.23

5.94

u/ml

1.70

133

(3022621) pH of Urine by Test strip

924

5690

1.68

44.74

2.8

2.6

—

(3026008) Bacteria identified in Urine by Culture

3209

25519

1.36

43.24

3.1

2.8

—

(40768804) Tissue Pathology biopsy report

4711

39688

1.31

42.41

2.1

—

(3045414) Leukocytes [Presence] in Urine

674

3865

1.79

42.08

1.9

1.8

—

(1761868) Lipid panel - Serum or Plasma

3015

37284

0.74

41.18

2.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

188

645

2.95

40.90

1.3

1.4

60784.91

94117.53

e6/l

0.45

134

430

(3000494) Fungus identified in Specimen by Culture

1532

10824

1.48

40.45

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

886

5628

1.62

37.78

7.6

24.72

24.60

mmol/l

0.47

834

5348

(3015171) Extractable nuclear Ab [Units/volume] in Serum

538

2990

1.84

37.20

1.3

1.2

0.60

1.14

u/ml

0.75

243

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

182

651

2.82

36.73

1.5

1.7

—

(3019060) Gas panel - Arterial blood

922

5957

1.59

36.60

5.3

5.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

664

3946

1.72

36.52

1.1

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

753

4629

1.67

36.52

2.5

2.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4082

34352

1.29

34.91

4.2

3.4

—

(4034850) Laboratory test

536

3059

1.79

33.94

10.0

8.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

898

5903

1.56

32.99

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4169

35429

1.28

32.24

5.1

4.8

2.21

3.14

ug/l

3.88

3814

31940

(3021788) Differential panel - Synovial fluid

273

1259

2.20

31.99

1.6

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9924

93997

1.38

31.54

13.1

12.4

80.90

80.61

ml/min/173m2

0.84

8360

77410

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1103

7667

1.48

31.13

2.4

361.23

379.49

nmol/l

2.49

1020

7107

(3014051) Protein [Presence] in Urine by Test strip

405

2190

1.88

30.54

2.5

2.4

—

(3023368) Bacteria identified in Blood by Culture

2947

24105

1.30

30.40

4.0

4.2

—

(3047181) Lactate [Moles/volume] in Blood

495

2867

1.76

29.79

6.0

6.7

1.28

1.33

mmol/l

0.50

434

2544

(3000570) Elastase.pancreatic [Mass/mass] in Stool

454

2571

1.80

29.50

1.4

282.63

262.65

ug/g

0.59

274

1525

(3021589) Normoblasts [#/volume] in Blood

3610

42289

0.79

29.35

8.9

9.3

0.00

e9/l

2.67

2968

34565

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1280

9255

1.43

29.29

1.8

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

421

2340

1.83

29.10

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2390

19114

1.32

28.89

1.6

73684641.88

33811156.22

pmol/l

1.60

2052

15850

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1280

9286

1.43

28.73

1.8

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

942

6447

1.50

28.62

3.6

4.0

81.50

93.58

ng/l

3.88

841

5595

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3694

31308

1.26

28.17

3.3

34.80

35.34

u/l

0.05

3519

29669

(3015377) Calcium [Moles/volume] in Serum or Plasma

3688

31302

1.26

27.66

2.8

3.8

2.35

2.36

mmol/l

1.87

3144

27693

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

891

6071

1.51

27.63

1.7

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

233

1072

2.20

27.52

1.4

1.3

35.84

35.94

u/l

0.01

178

870

(3000492) Spirometry study

1245

9069

1.42

27.23

1.5

—

(3016502) Oxygen saturation in Arterial blood

1293

9497

1.41

26.96

7.4

8.4

96.02

95.81

0.71

1230

9147

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

202

885

2.31

26.84

1.6

1.5

52.22

58.86

1.46

136

556

(3039000) Anion gap in Blood

373

2051

1.85

26.71

6.8

8.0

11.19

mmol/l

0.01

335

1840

(3018572) Chloride [Moles/volume] in Blood

373

2051

1.85

26.71

6.8

8.0

105.30

105.40

mmol/l

0.17

335

1840

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

389

2170

1.82

26.59

1.2

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

480

2851

1.71

26.42

2.3

479.13

719.33

ug/l

0.82

452

2692

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

694

4530

1.57

26.19

1.7

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1420

10662

1.38

25.89

7.1

7.9

12.23

12.66

kpa

2.51

1348

10205

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1420

10667

1.38

25.81

7.1

7.9

5.09

5.11

kpa

0.43

1344

10217

(3044941) Cell count panel - Synovial fluid

226

1056

2.16

25.70

1.5

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

442

2598

1.73

25.27

1.8

1.7

41.34

42.47

nmol/l

0.45

418

2521

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

386

2182

1.80

25.26

1.1

1.66

8.67

u/ml

4.64

299

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

339

1846

1.86

25.05

2.0

1.8

200.04

200.41

pmol/l

0.02

315

1747

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1028

7341

1.44

25.01

2.5

2.1

13.43

12.86

nmol/l

1.33

914

6604

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

521

3214

1.65

24.85

1.6

—

(4146454) Self-monitoring of blood glucose

218

1020

2.16

24.73

3.0

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

445

2640

1.71

24.60

1.7

—

(3003396) Base excess in Arterial blood by calculation

1410

10666

1.37

24.45

7.1

7.9

1.18

0.99

mmol/l

1.20

1125

8623

(3025941) Bacteria identified in Stool by Culture

700

4663

1.53

24.09

1.3

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

756

5120

1.51

24.07

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

421

2475

1.73

24.06

1.8

1.5

1.18

g/l

0.12

403

2350

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

724

4893

1.51

23.27

1.7

1.6

—

(3020891) Body temperature

560

3581

1.59

23.07

5.0

4.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

129

494

2.63

22.99

1.2

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

2825

23651

1.26

22.92

4.6

3.6

0.01

0.00

estimate

0.32

560

7834

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1192

8869

1.38

22.83

7.8

8.8

124.61

121.81

g/l

4.68

1145

8631

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1014

7345

1.42

22.73

3.0

2.7

147.14

188.86

ng/l

3.40

914

6708

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

405

2398

1.71

22.57

1.8

1.5

0.23

0.24

g/l

0.76

389

2264

(40761536) Microorganisms panel - Urine sediment

496

7654

0.63

21.66

4.4

3.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

126

492

2.58

21.62

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

592

3916

1.54

21.02

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

499

3176

1.60

20.98

2.8

2.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

510

3263

1.59

20.97

1.1

0.92

12.75

u/ml

0.98

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

506

7687

0.64

20.54

4.0

3.9

1.23

mmol/l

0.47

459

6742

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3290

28304

1.23

20.30

4.5

4.1

21.86

21.82

0.06

1615

13886

(3022145) Colonoscopy Study observation

1395

10830

1.33

20.12

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

702

4869

1.47

19.83

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

565

3748

1.53

19.81

1.4

1.5

9.61

12.77

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

225

1164

1.95

19.52

1.5

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

387

2363

1.66

19.26

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

387

2373

1.65

18.95

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

226

1184

1.93

18.91

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

380

2341

1.64

18.28

1.2

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

649

0.11

17.90

7.1

16.0

917.14

2944.31

nmol/l

—

623

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

617

0.10

17.68

5.7

11.8

632.67

866.39

nmol/l

—

593

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

758

5472

1.41

17.24

3.2

3.5

4.46

pmol/l

0.04

684

4895

(3043409) Potassium [Moles/volume] in Arterial blood

422

2710

1.58

17.13

4.9

4.4

3.85

3.89

mmol/l

1.17

417

2684

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

349

2.65

16.84

1.2

1.3

—

(40758558) Short blood count panel - Blood

2786

23942

1.22

16.75

6.0

7.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

530

3615

1.49

16.30

5.7

0.98

0.90

4.00

490

3379

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

392

2.51

16.12

1.1

2.26

7.67

u/ml

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1875

15528

1.25

15.96

2.8

2.7

1.05

1.33

e6/l

0.68

1214

8670

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

219

1205

1.83

15.82

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

953

7242

1.34

15.77

2.5

2.8

66.93

66.64

g/l

0.58

859

6647

(3017315) Amylase [Enzymatic activity/volume] in Urine

105

441

2.39

15.56

1.2

340.77

387.26

u/l

0.14

100

410

(3004588) Protein electrophoresis panel - Serum or Plasma

794

5878

1.38

15.54

2.4

2.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

888

6701

1.35

15.38

2.5

2.8

10.22

10.69

g/l

2.60

822

6149

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

533

3688

1.47

15.26

5.6

1.78

1.65

2.10

491

3445

(3036670) Protein [Mass/volume] in Synovial fluid

196

3.12

15.14

1.5

1.2

40.58

39.76

g/l

0.18

102

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

176

3.25

15.10

1.4

1.3

39.20

36.74

0.17

125

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

273

1625

1.70

15.05

1.2

29.46

43.93

u/ml

0.92

163

(3016244) Insulin [Units/volume] in Serum or Plasma

414

2.40

14.84

3.1

3.6

29.70

24.15

mu/l

0.71

391

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

258

1520

1.71

14.78

1.6

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

5.10

14.54

1.6

1.2

6.14

7.54

mmol/l

0.39

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

403

2668

1.53

14.33

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

168

3.22

14.16

1.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1675

13889

1.24

13.94

2.6

2.5

13.41

13.32

umol/l

0.20

1554

12995

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

215

1224

1.77

13.92

1.1

12.70

10.82

au/ml

0.12

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

295

2.62

13.90

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

102

446

2.30

13.85

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

881

6752

1.33

13.73

1.3

—

(3024263) Appearance of Synovial fluid

369

2.42

13.63

1.2

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1705

14211

1.23

13.49

1.9

2.0

29.17

29.85

4.86

1650

13817

(3009214) Lutropin [Units/volume] in Serum or Plasma

310

1961

1.60

13.49

1.4

1.3

11.28

11.60

u/l

0.15

256

1575

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

703

5224

1.37

13.44

8.8

10.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

109

497

2.20

13.41

1.1

8.20

8.64

iu/ml

0.06

124

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1373

11202

1.26

13.16

1.9

1.7

1.52

1.47

1.38

1204

9821

(3023520) Reticulocytes [#/volume] in Blood

943

7340

1.31

13.16

2.4

2.6

69.56

70.08

e9/l

0.17

780

5556

(3018405) Lactate [Moles/volume] in Arterial blood

453

3132

1.46

13.06

4.7

4.1

1.23

1.41

mmol/l

5.67

444

3075

(3008757) Leukocyte morphology finding [Identifier] in Blood

181

1002

1.82

12.91

3.5

3.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

352

2320

1.53

12.82

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

117

559

2.10

12.81

1.4

1.5

17.71

21.49

u/ml

0.68

115

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

248

1519

1.65

12.34

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

248

1519

1.65

12.34

1.6

1.8

—

(40762814) Titanium [Mass/volume] in Blood

152

3.17

12.27

2.3

3.13

3.82

ug/l

0.59

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

408

2804

1.47

12.16

1.9

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1313

10755

1.25

12.11

2.7

2.8

7.42

9.67

umol/l

3.16

1162

9434

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

291

1862

1.58

12.11

1.3

1.2

3.87

3.80

mmol/l

0.42

271

1766

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1548

12910

1.23

12.10

2.6

2.4

2.37

2.32

g/l

3.25

1448

11978

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1452

12029

1.24

12.08

5.7

6.0

1.04

1.03

mmol/l

0.87

1355

11300

(3027923) C peptide [Moles/volume] in Serum or Plasma

107

506

2.12

12.06

1.4

1.36

1.28

nmol/l

0.25

387

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

416

2.25

12.04

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

416

2.25

12.04

1.5

—

(3037121) Protein [Mass/volume] in Urine

438

3058

1.45

12.03

2.6

3.5

0.40

0.29

g/l

1.23

134

1428

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

102

474

2.16

12.02

1.2

60.91

101.35

titre

0.49

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

528

3816

1.40

11.97

2.1

2.0

41.82

39.12

u/l

2.32

463

3377

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

247

1535

1.62

11.63

1.2

—

(3018418) pH of Serum or Plasma

3055

27213

1.17

11.37

4.0

4.1

7.40

0.18

366

5286

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

728

5593

1.32

11.16

1.2

130.84

147.32

iu/ml

0.49

265

2177

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

200

1192

1.69

11.10

5.9

6.2

11.12

11.55

mg/l

0.77

190

1095

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

420

2956

1.44

11.07

1.4

1.6

178.82

306.27

titre

0.99

126

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1792

15304

1.20

10.93

3.2

3.7

0.82

mmol/l

0.90

1667

14415

(40768443) Skin Pathology biopsy report

551

4076

1.37

10.87

1.2

—

(3003338) MCHC [Mass/volume]

8629

82849

1.16

10.73

20.1

16.7

332.90

332.55

g/l

3.24

8596

82291

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

362

2.25

10.56

1.3

5.33

5.97

u/l

0.62

312

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

106

530

2.01

10.37

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

316

2137

1.49

10.27

1.4

1.3

575.64

586.85

mg/l

0.09

302

2034

(3019420) Tryptase [Mass/volume] in Serum or Plasma

420

2.13

10.16

1.3

1.7

8.19

9.95

ug/l

0.47

378

(40757494) Bilirubin.total [Moles/volume] in Blood

461

2.07

10.09

2.1

2.4

13.04

38.98

umol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

107

543

1.98

10.05

1.5

—

(3044927) Protein electrophoresis panel - Urine

146

820

1.79

10.04

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

258

2.45

10.03

1.2

1.3

—

(3049717) Cytology report of Urine Cyto stain

484

3554

1.38

10.02

2.5

2.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

160

924

1.74

10.00

2.9

3.5

56.58

57.43

0.20

137

787

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

755

9529

0.78

9.86

3.1

3.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

172

1026

1.69

9.58

1.2

43.98

63.54

u/ml

0.49

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

486

3602

1.36

9.52

2.2

2.0

2.88

2.48

ug/l

0.17

428

3231

(3014111) Lactate [Moles/volume] in Serum or Plasma

982

8000

1.25

9.47

6.7

7.6

1.26

1.35

mmol/l

2.52

965

7815

(3004119) Hemoglobin [Mass/volume] in Venous blood

682

5323

1.30

9.34

3.6

3.2

131.67

129.43

g/l

1.78

653

5202

(3045424) Erythrocytes [Presence] in Urine

237

1544

1.55

9.22

1.6

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1190

9929

1.22

9.16

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1915

16700

1.18

9.05

2.5

3.3

2.44

2.46

mmol/l

10.48

1703

14732

(3027315) Oxygen [Partial pressure] in Blood

119

2091

0.56

8.91

3.6

4.1

8.64

8.58

kpa

0.16

119

2043

(3023419) Bacteria identified in Sputum by Culture

217

1399

1.56

8.87

2.8

2.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

195

2.57

8.86

1.2

1.4

46.02

55.09

0.87

166

(3028026) IgM [Mass/volume] in Serum or Plasma

677

5319

1.29

8.83

1.7

1.9

1.39

1.37

g/l

0.07

604

4844

(3013290) Carbon dioxide [Partial pressure] in Blood

119

2076

0.57

8.69

3.6

4.1

5.03

5.00

kpa

0.16

119

2029

(3012501) Base excess in Blood by calculation

119

2074

0.57

8.66

3.6

4.0

2.46

2.59

mmol/l

0.22

1435

(3010421) pH of Blood

144

2388

0.60

8.66

3.6

4.0

7.42

0.15

131

2179

(3045683) HLA typing for celiac disease panel - Blood or Tissue

477

1.96

8.55

1.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1423

12169

1.19

8.43

2.7

2.5

23.58

23.18

0.46

1147

10430

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

343

2451

1.41

8.41

1.6

16.58

1.47

iu/ml

0.54

508

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

147

876

1.69

8.29

2.8

2.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

213

1390

1.54

8.28

1.5

1.6

0.59

0.88

g/l

5.26

168

1046

(3020717) Zinc [Moles/volume] in Serum or Plasma

395

2.03

8.20

1.4

1.5

24.89

27.98

umol/l

0.38

376

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

178

1119

1.60

8.14

1.1

2.12

3.47

u/ml

1.82

546

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

166

1026

1.63

8.14

1.5

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

166

1026

1.63

8.14

1.5

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

343

2471

1.40

8.04

2.3

2.0

11.38

11.13

mg/l

0.29

312

2324

(3026470) Cobalt [Mass/volume] in Blood

104

568

1.84

7.94

2.1

2.0

2.51

3.50

ug/l

1.69

517

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

163

1010

1.62

7.92

1.7

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

155

951

1.64

7.84

1.8

1.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

105

578

1.82

7.82

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

419

3133

1.35

7.82

2.5

2.4

2.79

2.94

g/l

2.12

360

2818

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

105

579

1.82

7.78

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

105

579

1.82

7.78

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

388

2870

1.36

7.76

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

747

6036

1.25

7.76

8.7

9.8

93.98

94.07

0.18

741

6017

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1245

10618

1.19

7.59

4.0

4.7

241.71

245.97

u/l

0.48

1176

10103

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

438

3316

1.33

7.53

2.5

2.4

3.56

3.75

g/l

1.74

379

3002

(44813793) Dust mix specific IgE antibody measurement

102

564

1.82

7.51

1.0

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

539

4203

1.30

7.49

3.4

3.2

25.43

25.23

mmol/l

0.72

517

4091

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

438

3321

1.33

7.46

2.5

2.4

7.33

7.31

g/l

0.05

379

3005

(3002385) Erythrocyte distribution width [Ratio]

8136

84165

0.89

7.45

16.9

15.7

16.20

15.05

25.18

8063

82556

(3020191) Ethanol [Moles/volume] in Serum or Plasma

123

722

1.71

7.38

1.4

1.28

1.36

promille

0.23

105

539

(40759836) Histone Ab [Presence] in Serum by Immunoblot

103

575

1.80

7.36

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

437

3320

1.33

7.35

2.5

2.4

—

(3044889) 12 lead EKG panel

7304

70008

1.12

7.34

4.1

3.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

117

679

1.73

7.32

1.3

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1328

11425

1.18

7.32

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

103

576

1.80

7.32

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

103

576

1.80

7.32

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

252

1754

1.45

7.21

1.5

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

193

1276

1.52

7.13

1.3

0.29

0.28

nmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

193

1278

1.52

7.08

1.3

0.58

1.71

nmol/l

0.66

181

1221

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

736

6008

1.24

7.00

8.8

9.6

1.47

1.37

1.60

726

5967

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

326

2.03

6.83

2.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

263

1868

1.42

6.76

1.6

1.4

3052.91

1778.06

e6/l

0.51

230

1521

(3012544) pH of Venous blood

993

8387

1.20

6.73

4.1

3.8

7.35

7.38

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

119

711

1.68

6.73

1.0

1.1

2766.91

285.27

mg/l

0.49

107

639

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

262

1867

1.41

6.62

1.5

1.4

32.53

33.05

e6/l

0.01

225

1426

(4281824) Cell count and differential, peritoneal fluid

1294

0.53

6.59

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

464

1.84

6.58

1.0

1.1

1.68

9.15

nmol/l

1.48

103

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

146

2.54

6.50

1.2

0.94

71.95

mg/l

1.00

115

(3000330) Specific gravity of Urine by Test strip

552

4404

1.27

6.44

3.0

3.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

729

6001

1.23

6.43

8.9

9.7

0.72

0.67

3.01

721

5963

(3051593) INR in Capillary blood by Coagulation assay

404

1.89

6.40

6.0

10.4

—

(3020491) Glucose [Moles/volume] in Blood

105

616

1.71

6.38

1.6

1.8

6.59

7.02

mmol/l

1.22

420

(3006462) Nitrate [Presence] in Urine

420

1.86

6.32

3.3

2.9

—

(3025577) Chromium [Mass/volume] in Blood

560

1.74

6.25

2.2

2.1

1.92

2.44

ug/l

1.38

464

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

130

813

1.61

6.19

1.7

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

130

813

1.61

6.19

1.7

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

130

813

1.61

6.19

1.7

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

274

1997

1.38

6.10

1.5

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

176

1186

1.49

6.01

2.2

1.9

8901.48

3205.54

u/l

0.69

431

(3034274) Bile acid [Moles/volume] in Serum --fasting

413

1.85

6.00

1.2

1.7

11.89

12.40

umol/l

0.03

300

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

279

2048

1.37

5.96

1.3

244.01

216.67

miu/ml

0.49

109

905

(3017143) Hepatitis C virus Ab [Presence] in Serum

1051

9028

1.18

5.90

1.5

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1143

9893

1.17

5.85

2.3

2.5

1.76

1.78

0.18

999

8799

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

278

2.02

5.78

1.4

1.2

2.81

3.87

umol/l

1.60

257

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

194

1344

1.45

5.78

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

132

844

1.57

5.76

1.4

1.3

0.36

0.43

g/l

2.13

101

588

(3028192) IgG subclass 2 [Mass/volume] in Serum

132

845

1.57

5.73

1.4

1.3

2.83

2.96

g/l

0.33

100

589

(3027135) IgG subclass 1 [Mass/volume] in Serum

132

846

1.57

5.70

1.4

1.3

6.11

7.15

g/l

2.08

587

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

280

2.00

5.67

1.4

14.58

15.43

pmol/l

0.55

246

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

201

1407

1.44

5.67

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2891

26672

1.11

5.55

1.8

1.6

1.41

1.37

mmol/l

1.77

2521

22205

(3028271) Lactate [Moles/volume] in Capillary blood

1450

0.60

5.50

1.6

1.8

1.59

1.75

mmol/l

1.20

1414

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

507

1.72

5.48

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

203

1435

1.42

5.45

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

298

2244

1.34

5.43

1.8

4.60

18.06

iu/l

0.73

821

(4035726) Immunohistochemistry procedure

824

9681

0.84

5.42

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

121

1857

0.65

5.37

2.7

3.6

43.65

35.70

u/ml

0.20

115

1805

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

549

1.68

5.33

1.2

1.1

44.99

45.04

mg/l

0.00

448

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

364

2828

1.30

5.31

2.5

2.4

0.97

0.98

g/l

0.02

300

2426

(3014271) Vancomycin [Susceptibility]

380

1.82

5.28

3.1

2.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

528

1.69

5.27

1.1

329.76

284.59

mg/l

0.42

450

(40767503) Oxygen content in Capillary blood by calculation

128

1931

0.66

5.24

2.6

2.5

16.21

16.43

0.26

1000

(4062490) Immunoglobulin typing, IgG

129

844

1.53

5.13

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

293

2224

1.33

5.09

1.6

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

169

1172

1.45

5.06

1.2

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

150

1018

1.48

5.02

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

382

0.26

5.01

1.7

2.5

114.10

151.50

nmol/l

—

337

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

324

2501

1.30

4.99

1.6

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1132

9913

1.16

4.99

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

230

1689

1.37

4.97

1.9

5.22

5.36

mmol/24h

0.27

205

1495

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

206

2.09

4.93

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

263

1978

1.34

4.88

1.5

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

761

6469

1.19

4.86

3.4

3.0

4.59

4.64

kpa

0.22

739

6262

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

391

3107

1.27

4.81

2.5

2.4

9.87

10.32

g/l

1.07

331

2768

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

111

716

1.56

4.74

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

118

772

1.53

4.73

1.4

1.3

145.00

166.03

pmol/l

1.14

118

772

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.58

4.62

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

126

843

1.50

4.57

2.1

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

414

1.72

4.53

1.5

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

154

2.21

4.51

1.1

0.55

1.12

umol/24h

0.69

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

207

2.03

4.50

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

2653

24611

1.10

4.44

3.8

3.9

93.57

90.77

7.37

2562

24037

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

470

1.66

4.43

1.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

503

1.63

4.35

1.9

2.1

—

(3002032) Base excess in Venous blood by calculation

922

8037

1.16

4.34

4.1

3.8

1.96

1.85

mmol/l

0.43

793

6841

(3009466) Valproate [Moles/volume] in Serum or Plasma

1410

0.64

4.31

3.5

5.3

360.10

375.16

umol/l

0.45

1224

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

105

686

1.54

4.28

1.4

1.3

2.16

2.22

mmol/l

0.26

642

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

475

5735

0.82

4.25

8.4

7.5

24.75

24.76

mmol/l

0.03

475

5685

(3035637) Corticotropin [Mass/volume] in Plasma

159

1130

1.41

4.24

1.6

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

219

1640

1.34

4.24

1.4

1.5

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

3.04

4.23

1.6

0.71

0.62

umol/l

0.33

(40768800) Prostate Pathology biopsy report

179

2437

0.73

4.21

1.2

—

(1616796) Gas panel - Central venous blood

141

1996

0.70

4.21

3.4

3.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

371

1.73

4.20

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

220

1.96

4.18

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

411

1.68

4.12

2.0

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

405

1.68

4.06

2.0

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

536

1.59

4.06

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

209

1.97

4.04

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

288

1.81

4.00

3.5

3.4

—

(3011288) Drugs identified in Urine by Screen method

169

1228

1.38

3.99

2.8

2.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

121

829

1.46

3.96

1.1

—

(3017704) Immunofixation for Urine

493

1.61

3.95

1.6

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

164

1188

1.39

3.95

1.0

0.33

1.20

u/ml

2.94

453

(3021447) Carbon dioxide [Partial pressure] in Venous blood

917

8051

1.15

3.94

4.1

3.8

5.87

5.80

kpa

1.35

890

7832

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

101

668

1.52

3.93

1.3

1.5

37.57

29.95

1.12

403

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

245

3154

0.77

3.91

1.5

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

503

1.59

3.89

1.9

2.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

323

2581

1.26

3.87

2.5

2.2

38.22

37.84

g/l

0.51

262

2265

(3003888) Timothy IgE Ab [Units/volume] in Serum

168

1226

1.38

3.87

1.0

1.1

1.72

3.84

u/ml

2.21

554

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

227

1.90

3.85

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

278

2184

1.28

3.84

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

209

1580

1.33

3.84

1.3

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

405

1.66

3.81

2.0

2.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.84

3.78

1.1

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

294

1.77

3.76

1.3

1.2

0.31

g/l

0.10

231

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

476

3980

1.20

3.73

1.8

1.7

1.58

1.57

g/l

0.01

408

3403

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

223

1.89

3.71

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

198

1494

1.33

3.70

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

158

1153

1.38

3.67

1.3

1.4

271.33

301.29

pmol/l

0.80

134

1001

(3000850) Epithelial cells [#/volume] in Urine

2012

18578

1.10

3.66

2.6

2.5

4.63

5.18

e6/l

1.33

1798

16638

(3002619) Bacteria identified in Specimen by Culture

142

2.12

3.63

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

167

1234

1.36

3.59

1.4

1.5

53.10

62.32

mu/l

0.39

151

1090

(3020876) Protein [Mass/time] in 24 hour Urine

141

1014

1.40

3.58

2.2

2.6

1.42

1.30

g/24h

0.14

511

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.78

3.55

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

289

2306

1.26

3.54

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

325

2630

1.24

3.53

1.2

1476.67

968.30

titre

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

199

1516

1.32

3.50

1.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

255

2009

1.28

3.48

1.9

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

253

1995

1.27

3.44

1.9

2.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

293

2352

1.25

3.43

2.1

2.3

103.10

98.44

ug/min

0.07

174

1411

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

600

1.50

3.42

2.9

2.6

537.29

521.36

e6/l

0.14

514

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

115

805

1.43

3.42

1.1

1.2

—

titre

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

2.30

3.42

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

406

0.42

3.41

1.9

2.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

196

1497

1.31

3.40

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

123

873

1.41

3.39

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

224

1.83

3.35

1.2

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

127

2.13

3.34

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

210

1.86

3.33

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

235

1844

1.28

3.33

2.0

—

(36304419) Bacteria [Presence] in Urine

2597

24359

1.09

3.30

3.2

2.9

—

(3025159) Blasts/100 leukocytes in Blood

614

7080

0.86

3.29

3.8

4.1

0.39

0.47

0.12

205

2064

(3023383) Lactate [Moles/volume] in Pleural fluid

277

1.74

3.28

1.2

1.3

3.41

3.70

mmol/l

0.18

255

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

345

1.66

3.28

1.2

1.1

121.64

681.19

ng/l

1.90

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

169

1.96

3.27

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

487

1.54

3.24

2.2

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

199

1.86

3.19

1.2

1.3

81.36

67.65

mu/l

0.12

153

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

178

1356

1.32

3.17

1.1

0.70

1.71

u/ml

2.63

633

(40768795) Lymph node Pathology biopsy report

1101

0.66

3.15

1.1

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

3.13

0.0

6.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

373

1.61

3.13

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

257

2057

1.26

3.12

1.7

1.8

302.83

306.21

mu/l

0.05

238

1877

(3017817) Protein [Mass] in Urine collected for unspecified duration

110

779

1.42

3.10

2.4

2.3

—

0.61

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

166

1.93

3.08

1.7

1.3

—

(3037756) Immunofixation for Serum or Plasma

244

1945

1.26

3.07

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

347

1.62

2.97

1.4

1.7

2.09

2.01

umol/l

0.27

327

(3027008) Opiates [Presence] in Urine

249

2002

1.25

2.93

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

334

1.62

2.90

1.5

159.72

136.14

umol/l

0.26

154

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

381

1.58

2.89

1.6

1.7

3.01

11.30

nmol/l

0.72

321

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

122

2.05

2.86

1.2

1.3

1483.17

314.51

u/l

0.37

(3017569) Oxygen content in Arterial blood

416

0.48

2.85

2.1

2.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

248

2000

1.25

2.85

2.0

1.7

0.90

0.82

nmol/l

0.92

203

1704

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

252

1.71

2.83

1.2

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

1304

1.30

2.79

1.4

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

216

1.76

2.78

1.7

1.6

0.35

0.39

ug/l

0.31

143

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

284

1.66

2.77

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

224

1.74

2.76

1.2

1.1

211.38

284.46

pmol/l

1.28

175

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

613

1.44

2.76

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

119

874

1.37

2.75

2.8

3.0

98.18

38.03

mg/l

0.68

620

(3035320) C reactive protein [Mass/volume] in Body fluid

630

1.43

2.75

3.3

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

371

1.57

2.73

1.1

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

170

1320

1.29

2.69

1.1

1.47

1.52

g/l

0.95

151

1197

(3007566) Smooth muscle Ab [Titer] in Serum

317

2640

1.21

2.69

1.2

95.00

152.53

titre

0.95

245

(3004809) Band form neutrophils/100 leukocytes in Blood

195

1542

1.27

2.68

2.8

3.4

1.43

1.71

0.62

174

1386

(3000012) Reticulocyte production index

1330

0.72

2.67

1.8

2.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

302

2507

1.21

2.66

2.7

2.3

0.00

0.02

g/l

1.81

272

2289

(3006270) Folate [Moles/volume] in Blood

677

1.41

2.65

1.2

1.1

337.37

368.27

nmol/l

0.78

578

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

147

1.91

2.64

1.3

1.2

57.61

665.39

ng/l

0.61

103

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

480

1.48

2.61

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

141

1.92

2.59

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

440

0.52

2.58

1.6

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

246

2008

1.23

2.57

5.8

6.2

285.86

1455.65

iu/ml

0.98

317

(3018095) Leukocytes [#/volume] in Urine

3343

31913

1.07

2.55

3.8

3.5

67.87

103.68

e6/l

2.04

2455

22314

(3052592) Norovirus Ag [Presence] in Stool

156

1.86

2.55

1.3

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

100

724

1.38

2.55

1.0

769.18

725.44

ng/l

0.40

502

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.35

2.55

1.3

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

109

802

1.36

2.53

1.7

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

100

726

1.38

2.52

1.0

40.81

42.15

ng/l

0.14

508

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

461

1.48

2.49

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

328

3877

0.84

2.47

3.1

3.8

96.90

1091.38

u/ml

4.16

281

3349

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

162

1266

1.28

2.47

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

144

1108

1.30

2.47

1.0

1.1

0.58

1.17

u/ml

1.61

492

(3005033) Fetal Nuchal fold Thickness US

420

0.52

2.47

1.5

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

4.38

2.47

1.1

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

333

2812

1.19

2.46

3.6

33.13

48.06

mg/l

1.92

302

2233

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

130

1.93

2.44

1.3

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

115

860

1.34

2.42

1.4

1.2

1.56

1.42

nmol/l

0.59

101

783

(3026782) Osmolality of Urine

1658

17759

0.92

2.42

2.9

2.8

529.43

548.59

mosm/kgh2o

3.04

1395

15274

(3027944) Amphetamines [Presence] in Urine

240

1970

1.22

2.40

1.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.06

2.36

2.3

0.70

0.48

u/field

0.44

(3023410) Appearance of Cerebral spinal fluid

110

821

1.34

2.35

1.8

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1160

0.72

2.34

5.0

2.5

13.46

13.25

1.09

1144

(3021440) Promyelocytes/100 leukocytes in Blood

669

7476

0.89

2.33

3.7

4.1

0.06

0.12

2.05

253

2447

(3028707) Methadone [Presence] in Urine by Screen method

112

840

1.34

2.32

2.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

543

1.42

2.32

1.6

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

678

1.37

2.31

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

423

0.54

2.31

1.6

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

721

1.36

2.31

1.0

296.54

378.75

ng/l

0.80

514

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

733

0.65

2.30

1.6

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

661

5904

1.13

2.30

1.3

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

2651

25195

1.07

2.30

3.3

3.0

0.33

0.44

e6/l

1.98

2073

18823

(21494890) Protein electrophoresis panel - 24 hour Urine

126

965

1.31

2.27

2.1

2.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.22

2.27

1.1

1.84

1.87

umol/24h

0.04

(3034860) Kappa light chains.free [Mass/volume] in Serum

331

2817

1.18

2.27

3.7

3.6

43.66

52.75

mg/l

1.36

302

2236

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

278

2330

1.20

2.27

2.7

2.3

0.00

g/l

0.50

249

2121

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

156

0.32

2.26

3.2

2.6

—

81.08

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.89

2.25

5.3

5.8

0.39

0.20

mmol/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

159

1258

1.27

2.24

1.3

1.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

5.56

2.21

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

5.56

2.21

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

5.56

2.21

2.0

—

(3007463) Buprenorphine [Presence] in Urine

5.56

2.21

5.8

10.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

5.56

2.21

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

5.56

2.21

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

5.56

2.21

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

121

1.90

2.20

1.9

1.2

43.64

53.08

0.40

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

583

1.39

2.19

1.5

1.3

1.19

1.25

u/ml

0.03

317

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

529

0.60

2.19

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

558

1.40

2.19

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

129

1.86

2.16

1.3

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1554

14526

1.08

2.15

3.1

2.8

2.22

2.36

e6/l

0.23

910

7719

(3027231) Wheat IgE Ab [Units/volume] in Serum

130

1.85

2.11

1.0

1.54

2.93

u/ml

0.27

107

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

813

0.69

2.11

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

267

1.58

2.10

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.21

2.10

2.0

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

555

1.39

2.08

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

533

0.62

2.07

1.6

—

(3008295) Osmolality of Serum or Plasma

114

874

1.31

2.07

1.4

279.05

278.27

mosm/kgh2o

0.12

712

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

373

1.48

2.06

1.0

1.1

106.86

97.60

1.09

289

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

144

1139

1.27

2.06

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

473

1.42

2.05

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

161

1292

1.25

2.04

2.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

474

1.42

2.02

1.1

1.06

1.08

ratio

0.31

169

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

627

1.36

2.01

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

177

1.70

2.01

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

177

1.70

2.01

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

177

1.70

2.01

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

177

1.70

2.01

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.05

2.00

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

404

3532

1.15

2.00

1.7

1.6

4.04

3.96

mg/l

0.05

332

2534

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

216

1.62

1.99

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

629

1.35

1.98

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

410

1.44

1.97

1.1

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

187

1533

1.22

1.96

2.7

656.80

8000.98

u/ml

0.67

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

179

1461

1.23

1.96

1.1

38.00

704.01

iu/ml

0.87

302

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1000

9215

1.09

1.96

2.5

2.3

0.22

0.21

g/l

2.41

940

8611

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

318

2738

1.17

1.94

3.7

3.5

1.84

3.16

ratio

0.85

179

(3026692) Albumin [Mass/volume] in Peritoneal fluid

283

0.49

1.94

1.4

1.5

8.79

12.59

g/l

—

218

(3036071) Salmonella sp Ab [Titer] in Serum

210

1.62

1.93

1.1

—

(3028433) Virus identified in Specimen by Culture

330

1.49

1.92

1.3

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

203

1.63

1.91

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

859

9362

0.91

1.91

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

1.89

1.90

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

196

1621

1.21

1.90

1.2

257.55

282.56

u/ml

0.73

112

1036

(3023323) Follitropin [Units/volume] in Serum or Plasma

388

3397

1.15

1.90

1.3

35.78

36.74

iu/l

0.19

345

2919

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

2.00

1.89

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

918

8445

1.09

1.88

8.3

7.5

9.41

9.61

mmol/l

0.39

856

8078

(3016018) Differential panel - Cerebral spinal fluid

120

941

1.28

1.87

1.7

1.5

—

(3003181) Sodium [Moles/volume] in Urine

185

1524

1.22

1.87

1.4

64.49

63.15

mmol/l

0.15

154

1189

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.98

1.84

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

859

0.72

1.84

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

392

1.43

1.82

1.0

1.1

0.97

1.19

u/l

1.84

202

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

310

1.49

1.82

1.8

2.0

52.42

56.46

ug/l

0.22

302

(3013727) Leukocytes other/100 leukocytes in Blood

315

0.54

1.81

2.6

3.5

46.53

54.14

0.74

305

(3036603) Volume of Urine

674

1.32

1.81

1.7

1.5

1896.67

1913.77

0.07

654

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

168

1.67

1.79

1.1

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

105

815

1.29

1.79

4.2

5.5

67.68

93.68

u/ml

0.43

252

(3012494) Peanut IgE Ab [Units/volume] in Serum

161

1.68

1.77

1.1

1.0

0.29

1.07

u/ml

0.72

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.34

1.77

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

721

7891

0.91

1.77

3.6

4.1

0.79

0.99

1.57

308

2845

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2175

20712

1.06

1.76

3.1

2.9

0.69

0.77

ug/l

2.30

1474

13635

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

898

0.73

1.76

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.03

1.74

1.9

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

550

6099

0.90

1.74

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

195

2326

0.84

1.73

4.0

3.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

183

1520

1.21

1.73

1.3

22.91

36.76

u/l

2.48

161

1313

(3015235) Bicarbonate [Moles/volume] in Capillary blood

257

2200

1.17

1.72

2.9

3.0

24.86

24.75

mmol/l

0.17

251

2155

(3022493) Free Hemoglobin [Mass/volume] in Plasma

339

1.45

1.71

6.9

5.7

76.96

1233.89

mg/l

0.82

248

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

103

1.85

1.71

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

266

1.51

1.70

1.6

9.74

8.84

ug/l

0.57

266

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

210

1.57

1.70

1.3

2.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

451

4025

1.13

1.68

1.4

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

309

1.46

1.65

1.6

1.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.93

1.64

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

207

1749

1.19

1.64

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1053

0.77

1.60

1.8

1.6

—

(3003694) ABO and Rh group [Type] in Blood

2477

25827

0.95

1.60

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

219

2564

0.85

1.59

2.9

1.55

1.53

mg/l

0.11

198

2357

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

222

1.53

1.58

3.0

7.39

7.42

mg/l

0.01

180

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

114

1.76

1.56

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

518

0.67

1.54

1.2

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.43

1.53

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

245

2113

1.16

1.53

3.4

3.8

—

(3000991) Gas panel - Venous blood

841

7787

1.09

1.53

8.4

8.9

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

1.52

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.16

1.50

2.3

2.8

—

(3024928) Oxygen saturation in Venous blood

219

1876

1.17

1.50

4.2

3.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

123

1.71

1.50

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

370

0.62

1.50

2.3

1.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

265

2304

1.15

1.50

2.8

2.4

0.00

g/l

-0.00

244

2115

(3023430) Cat dander IgE Ab [Units/volume] in Serum

115

927

1.24

1.49

1.1

1.0

3.46

3.49

u/ml

0.01

330

(3020393) Adenovirus Ag [Presence] in Stool

1.90

1.49

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

131

1.68

1.49

1.1

1.3

1.35

0.84

mmol/l

0.30

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

367

1.39

1.48

1.6

1.8

192778.86

21765.67

u/ml

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

561

5109

1.10

1.48

8.8

10.0

24.33

24.31

mmol/l

0.04

549

4972

(3036180) Methadone [Presence] in Urine

243

1.48

1.46

1.9

2.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

171

1.58

1.45

1.1

1.2

1.80

1.75

mmol/l

0.09

106

(3009677) Dengue virus Ab [Presence] in Serum

2.50

1.45

1.1

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.13

1.44

1.2

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

528

4805

1.10

1.42

2.5

2.7

0.21

0.33

e6/l

2.01

512

4683

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

430

1.35

1.42

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

259

2260

1.15

1.41

1.7

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

221

1.49

1.40

1.4

2.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

363

1.38

1.39

1.0

1.1

3.00

4.03

u/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

182

1553

1.17

1.34

1.0

1.1

—

(40768793) Breast Pathology biopsy report

195

2266

0.86

1.34

1.4

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.78

1.32

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.32

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

593

0.72

1.32

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

101

816

1.24

1.32

1.0

0.03

0.64

u/ml

1.49

207

(3036489) Thrombin time

374

3359

1.12

1.31

1.9

21.48

21.65

0.15

314

2969

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1433

13606

1.06

1.31

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

192

1.51

1.31

7.8

7.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

121

1.65

1.30

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

1084

0.80

1.28

1.9

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

920

8622

1.07

1.27

2.8

2.4

48.68

45.54

u/l

0.08

781

7424

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

139

1166

1.19

1.26

1.2

7.72

7.64

mmol/l

0.09

118

1018

(3014133) Dog dander IgE Ab [Units/volume] in Serum

121

1003

1.21

1.25

1.1

1.0

2.87

3.09

u/ml

0.09

432

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

688

1.25

1.24

1.2

1.3

10.47

13.95

u/l

2.33

643

(3029075) Extractable nuclear Ab panel - Serum

236

1.44

1.24

1.0

—

(3044007) Cell count panel - Peritoneal fluid

339

0.65

1.23

1.7

1.8

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.00

1.23

1.1

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

116

1.64

1.21

10.7

6.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

502

0.72

1.21

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

501

0.72

1.19

1.6

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

101

1.68

1.19

1.1

1.0

0.01

0.32

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

340

1.35

1.19

1.6

1.7

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.31

1.18

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

430

0.70

1.18

1.3

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

499

0.72

1.17

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

499

0.72

1.17

1.6

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

370

0.67

1.17

1.9

1.8

11304.47

13533.59

e6/l

0.12

211

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

231

1.43

1.16

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

402

1.32

1.16

1.2

173.14

166.14

mmol/24h

0.26

402

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

376

1.33

1.16

1.9

2.2

46.78

52.62

umol/l

0.71

319

(3013762) Body weight Measured

0.00

1.16

0.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

190

1.47

1.15

1.1

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

342

1.35

1.15

2.1

3.3

28.65

28.91

umol/l

0.05

265

(3014599) Egg white IgE Ab [Units/volume] in Serum

430

1.30

1.13

1.0

1.83

0.47

u/ml

0.52

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

294

0.65

1.11

1.2

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

424

0.71

1.11

2.5

1.9

890.17

2815.49

e6/l

0.53

298

(3012898) Urea [Moles/volume] in Urine

1.71

1.11

1.2

1.4

175.67

178.03

mmol/l

0.03

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.78

1.10

1.1

1.0

0.32

1.34

u/ml

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.26

1.10

1.0

0.00

0.10

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

114

955

1.20

1.09

1.4

0.25

0.28

nmol/l

0.45

698

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

146

1250

1.17

1.09

1.2

3.00

3.87

u/ml

1.05

550

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

149

1278

1.17

1.09

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

160

1.50

1.09

1.2

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

451

1.29

1.08

2.9

2.0

105.07

166.88

ug/min

0.34

101

(3028679) Herpes simplex virus Ab [Presence] in Serum

381

1.31

1.08

1.3

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

569

0.75

1.06

1.2

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

262

1.38

1.05

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

884

9366

0.94

1.05

1.9

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

672

7181

0.93

1.03

3.4

3.9

0.67

0.76

0.47

282

2446

(3020650) Glucose [Presence] in Urine

240

0.62

1.03

2.0

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

697

1.22

1.03

1.2

8.80

9.21

mmol/l

0.38

656

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

347

0.69

1.02

1.4

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

181

1585

1.14

1.02

1.2

—

(3021901) Oxygen saturation in Capillary blood

139

1613

0.86

1.01

2.9

2.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

541

0.76

1.00

1.5

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

430

1.28

1.00

1.1

1.0

0.59

1.40

u/ml

0.54

122

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

222

1.40

1.00

1.5

1.3

141.68

132.75

nmol/l

0.11

167

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.84

0.98

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

240

1.38

0.98

8.6

7.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

335

1.31

0.98

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.63

0.97

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.63

0.97

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.74

0.96

1.2

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

250

1.36

0.95

1.6

1.8

10.58

9.35

mg/l

0.49

200

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

185

0.59

0.93

1.2

—

(40768806) Pleura Pathology biopsy report

1009

0.83

0.93

1.6

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

109

1.56

0.93

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

436

1.26

0.92

1.1

1.3

70.33

53.98

—

(40765096) Chromosome analysis panel by Banding

304

1.32

0.91

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

121

1039

1.17

0.91

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

278

1.33

0.91

8.5

8.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

102

1.57

0.90

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

148

1294

1.15

0.88

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

127

1.50

0.88

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

148

1295

1.14

0.88

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

584

0.79

0.87

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

203

1.38

0.86

1.1

1.0

3.29

10.26

u/ml

2.85

118

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

530

1.23

0.86

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

334

1.29

0.85

2.4

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

246

2225

1.11

0.85

3.2

3.7

647.14

677.91

u/ml

0.03

223

2039

(3043410) Blood group antigens tested for on Red Blood Cells

238

1.35

0.85

1.6

1.5

—

(1002224) Polysomnography panel

437

4059

1.08

0.85

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.94

0.84

1.0

1.4

—

(3004775) Volume in Urine collected for unspecified duration

768

0.82

0.84

2.3

663.75

674.65

0.06

536

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.76

0.83

1.0

9.90

12.53

u/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

318

1.29

0.83

1.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

194

2164

0.89

0.82

1.7

1.5

—

(3002256) Pathology report gross observation

1359

13087

1.04

0.78

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

1.67

0.78

1.0

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

203

1830

1.11

0.77

1.4

22.88

22.64

u/ml

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1041

0.85

0.77

2.3

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

171

1528

1.12

0.76

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.77

0.76

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

252

1.31

0.76

2.9

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

252

1.31

0.76

2.9

2.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

110

955

1.15

0.76

1.2

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

780

1.17

0.74

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

439

4105

1.07

0.74

4.6

4.2

24.19

23.99

mmol/l

0.64

430

4018

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

763

1.17

0.73

1.6

—

(3016228) CD19 cells/100 cells in Blood

413

0.77

0.72

1.6

2.0

5.84

8.62

1.30

401

(3007700) Barley IgE Ab [Units/volume] in Serum

2.00

0.72

1.0

0.11

0.65

u/ml

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.00

0.72

1.0

1.2

—

(3045788) Cell count panel - Pleural fluid

862

0.85

0.72

1.4

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

1.75

0.71

1.0

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

489

0.80

0.70

2.4

191.49

201.52

u/l

0.84

480

(3024891) Influenza virus A+B Ag [Presence] in Specimen

229

2090

1.10

0.70

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

841

1.15

0.70

2.3

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

160

1.38

0.70

1.2

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

284

2620

1.09

0.69

2.6

3.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

145

1293

1.12

0.69

1.2

3.36

4.15

u/ml

0.20

461

(3050129) First trimester maternal screen panel - Serum or Plasma

618

0.82

0.68

1.6

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

1017

0.86

0.68

5.3

14.0

7.68

7.45

mmol/l

0.18

849

(3051101) Glucose [Moles/volume] in Cord blood

168

0.65

0.67

6.0

6.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

234

2146

1.09

0.66

2.8

36.66

34.31

umol/l

0.26

207

1938

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

688

1.16

0.65

1.4

12.41

12.39

u/l

0.01

668

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

467

1.20

0.65

1.6

1.7

1.69

2.26

u/field

0.31

324

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

103

1.46

0.64

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

392

0.79

0.62

1.6

1.7

—

(3014891) Appearance of Pleural fluid

101

0.59

0.62

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

138

1238

1.12

0.62

1.1

119.92

117.50

0.32

118

1112

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

479

0.81

0.61

2.2

3.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

401

0.80

0.60

1.6

2.0

—

(3002582) Erythrocytes [#/volume] in Urine

2804

27486

1.03

0.60

3.4

3.1

46.81

104.01

e6/l

2.46

2205

20742

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

427

1.20

0.58

3.7

4.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1132

10948

1.04

0.57

3.4

4.4

20.52

29.83

ug/l

0.66

934

8903

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

420

0.81

0.57

3.4

2.8

—

(3035285) Chloride [Moles/volume] in Venous blood

1053

0.88

0.57

2.3

2.2

105.95

105.17

mmol/l

1.09

1040

(3041354) Potassium [Moles/volume] in Venous blood

1053

0.88

0.57

2.3

2.2

4.05

mmol/l

0.03

1040

(3035880) pH of Pleural fluid

503

1.17

0.56

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.62

0.55

1.2

1.1

—

(3019174) dRVVT (LA screen)

1.54

0.55

1.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

203

1.28

0.55

2.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.49

0.53

1.2

0.17

0.31

nmol/l

—

(3010375) cycloSPORINE [Mass/volume] in Blood

480

0.83

0.52

28.1

28.3

119.84

117.26

ug/l

0.09

403

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

854

1.13

0.52

3.6

3.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

359

1.20

0.52

1.0

1.1

1551.12

1450.59

miu/ml

0.23

359

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.62

0.52

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

758

0.87

0.51

1.2

90.00

165.61

titre

—

123

(3032352) Blasts [#/volume] in Cerebral spinal fluid

100

0.60

0.51

1.0

1.8

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

161

1.30

0.51

1.2

1.1

61.09

61.85

u/ml

0.02

155

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

191

0.73

0.50

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.38

0.50

2.0

2.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

118

1.36

0.50

1.4

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

109

983

1.11

0.48

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

365

0.82

0.46

1.4

1.8

2.49

8.48

ug/l

1.30

239

(3050794) Legionella sp Ab [Presence] in Serum

1.41

0.46

1.1

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.46

0.46

1.0

0.65

0.19

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

188

0.74

0.46

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

617

1.14

0.46

3.0

2.6

0.12

0.37

e9/l

1.27

599

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.38

0.45

1.0

1.1

—

(3048879) Bone marrow aspiration report

273

1.21

0.45

2.2

2.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

301

1.20

0.45

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.40

0.45

1.3

2.0

1.92

1.98

mg/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

219

1.23

0.45

2.3

2.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

201

1.24

0.44

1.6

1.7

2.50

2.31

ug/l

0.09

115

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.45

0.44

3.2

1.6

44.00

39.93

umol/l

—

(3016038) Potassium [Moles/volume] in Urine

563

1.14

0.44

1.1

1.2

39.61

34.48

mmol/l

0.87

487

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

178

1653

1.08

0.44

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

127

0.71

0.43

1.0

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.41

0.43

8.1

5.9

—

(3010937) Rubella virus Ab [Presence] in Serum

1.61

0.43

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

185

0.76

0.43

1.1

—

(3016750) Collection duration of Urine

554

0.87

0.42

2.1

2.2

504.77

493.89

min

0.32

426

(3023199) Leukocytes [#/volume] in Pleural fluid

121

1107

1.09

0.42

1.3

1.4

3714.23

3035.47

e6/l

0.15

793

(21494434) Karyotype in Bone marrow

839

0.89

0.42

1.1

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.56

0.42

7.2

5.5

395.20

431.69

umol/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

880

0.90

0.41

1.3

6.60

6.22

mmol/l

0.48

811

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.52

0.41

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

158

1470

1.08

0.39

2.9

0.74

0.81

nmol/l

1.58

110

1127

(3015076) Soybean IgE Ab [Units/volume] in Serum

400

1.15

0.38

1.1

1.0

0.33

1.11

u/ml

0.42

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

463

0.86

0.38

1.1

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.34

0.38

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

354

1.16

0.38

1.3

1.4

1.29

3.23

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

290

0.83

0.37

1.3

17.13

34.20

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.30

0.37

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

725

0.90

0.36

1.1

1.4

1.64

1.56

g/l

0.97

725

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.29

0.36

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

215

2029

1.06

0.36

2.1

2.2

130.48

130.83

g/l

0.07

126

1421

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

253

2666

0.95

0.36

1.8

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

189

1.22

0.36

1.8

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

659

0.89

0.34

1.9

2.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

264

1.17

0.34

1.4

1.2

11.94

373.69

ug/l

2.16

146

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.36

0.34

1.0

1.3

1.35

1.33

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.33

0.33

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

194

1832

1.06

0.33

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.30

0.33

1.3

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.68

0.33

2.2

2.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

686

0.90

0.32

1.8

1.9

1.91

1.82

u/field

0.05

281

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.35

0.31

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

176

1662

1.06

0.31

1.4

113.39

118.97

u/ml

0.34

362

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

228

2171

1.05

0.30

1.7

1.4

91.95

150.48

pmol/l

4.19

223

2126

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.30

0.30

1.4

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

381

1.13

0.30

1.3

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

247

2585

0.95

0.29

2.4

2.3

192.64

197.11

0.36

235

2471

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.25

0.29

1.0

1.1

—

16.85

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2379

24095

0.98

0.29

3.1

3.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

119

1272

0.93

0.29

1.5

—

(3047189) Immunofixation for 24 hour Urine

461

0.89

0.28

2.2

1.9

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

593

1.10

0.28

1.1

1.3

93.56

90.90

u/l

0.07

523

(3017509) Phencyclidine [Presence] in Urine

1.27

0.27

1.8

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

854

1.08

0.27

1.3

312.80

574.74

u/l

2.12

815

(3000060) B lymphocytes [#/volume] in Blood

205

1.17

0.27

1.7

2.0

135.33

1711.36

e6/l

0.73

110

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.28

0.26

1.1

1.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.70

0.26

1.6

1.4

11.98

20.41

pmol/l

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.70

0.26

2.6

2.0

21.80

22.29

mg/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.69

0.26

1.0

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

522

5079

1.03

0.25

3.0

3.9

39.77

55.17

u/ml

0.81

501

4913

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

123

1.22

0.25

1.3

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

234

0.85

0.24

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

236

1.14

0.24

1.0

1.1

95.92

88.05

0.69

109

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

218

1.15

0.23

1.3

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.28

0.23

12.2

9.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.28

0.23

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.77

0.22

4.0

2.9

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.22

0.22

5.0

8.7

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.19

0.21

1.2

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.3

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.5

—

13.50

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

181.01

—

(3028717) Thiamine [Mass/volume] in Blood

1.22

0.21

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

109

1150

0.95

0.20

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

112

0.80

0.20

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

288

1.11

0.19

1.3

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.21

0.19

1.4

1.5

6.12

7.07

mmol/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

118

1.19

0.19

1.8

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

193

2001

0.96

0.18

3.6

3.2

20.21

27.95

mg/l

1.83

1270

(3005011) Chlamydia sp Ab [Titer] in Serum

109

1.19

0.18

1.6

1.7

—

(3042517) Benzodiazepines panel - Urine

1.21

0.18

2.6

2.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

100

1.20

0.18

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

300

0.90

0.18

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.21

0.17

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

0.84

0.17

6.1

5.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.75

0.17

1.0

1.1

9.46

8.48

mmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.75

0.17

1.4

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.74

0.17

3.6

1.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

914

1.05

0.16

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

244

1.11

0.16

1.0

1.1

82.25

87.58

0.25

111

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

244

2372

1.03

0.16

1.2

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

325

3173

1.02

0.16

3.2

2.9

0.36

0.35

u/ml

0.24

194

1769

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.10

0.15

4.4

5.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.20

0.15

1.0

1.1

—

(3004451) EKG impression Narrative

400

1.08

0.15

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.80

0.14

2.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

169

1.12

0.14

3.3

1.9

120.84

44.36

pmol/l

0.45

143

(3012441) Differential panel - Pleural fluid

962

0.96

0.14

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.78

0.14

8.0

5.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

201

0.90

0.13

6.1

6.4

67.91

69.60

0.08

158

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

107

0.84

0.13

1.0

1.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

579

1.05

0.13

1.1

1.3

25.87

21.68

u/l

0.29

503

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

258

1.09

0.12

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.18

0.12

1.1

5.11

9.68

mg/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

179

0.89

0.12

1.5

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

114

1.14

0.11

1.1

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

172

1.10

0.11

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

103

995

1.04

0.11

2.6

3.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

278

2834

0.98

0.11

2.1

92.40

90.37

0.76

262

2721

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

563

1.05

0.11

3.5

3.0

37.59

36.44

0.17

302

(40768441) Liver Pathology biopsy report

790

0.96

0.10

1.4

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

170

1661

1.02

0.10

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.11

0.09

1.4

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

108

1048

1.03

0.09

1.1

1.2

63.42

62.11

u/l

0.06

101

943

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.06

0.09

1.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

192

1881

1.02

0.09

2.8

2.9

8.20

8.11

kpa

0.41

187

1843

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

797

0.97

0.09

1.6

1.9

3.19

3.82

mg/l

1.48

761

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

268

2724

0.98

0.09

2.4

3.61

3.63

g/l

0.06

260

2606

(3034426) Prothrombin time (PT)

298

0.94

0.08

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.09

0.08

1.0

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.06

0.08

1.6

1.4

101.57

1400.20

u/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.03

0.07

1.6

2.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

632

0.97

0.07

1.4

12.93

12.79

umol/l

0.06

599

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

935

1.03

0.07

2.3

2.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.07

0.07

1.3

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

621

0.97

0.07

1.6

6.29

6.08

u/l

0.06

497

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

619

1.03

0.07

5.8

6.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

108

1.11

0.07

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

471

4757

0.99

0.07

1.7

—

(3022689) Creatine [Moles/volume] in Urine

294

1.05

0.07

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

206

1.07

0.07

1.2

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

265

0.94

0.07

2.7

2.0

17.55

33.50

u/l

1.28

242

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

128

1.09

0.06

1.6

2.0

14.34

18.53

umol/l

0.91

128

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

443

1.04

0.06

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

443

1.04

0.06

1.3

1.5

—

(3011648) Oxygen content in Venous blood

713

1.02

0.05

2.4

2.2

10.45

11.34

1.03

713

(40758292) HTLV I+II Ab panel - Serum

169

1.07

0.05

1.4

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

130

1.08

0.04

1.7

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

255

2527

1.01

0.04

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

171

1693

1.01

0.03

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

171

1693

1.01

0.03

1.2

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

179

0.95

0.03

1.0

1.2

133.82

106.56

2.92

166

(3000285) Sodium [Moles/volume] in Blood

118

0.93

0.02

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

122

1.07

0.02

14.8

9.6

5.90

5.44

mmol/l

0.13

122

(3051651) Icteric interference index of Serum or Plasma

601

0.98

0.02

2.6

3.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

167

0.96

0.01

3.1

3.3

—

(3019977) pH of Arterial blood

488

0.98

0.01

2.5

2.7

7.43

7.42

—

180

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

688

0.99

0.01

1.6

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

169

1681

1.01

0.01

3.3

3.1

—

(3024932) HLA-DR beta [Type]

367

0.98

0.01

1.1

—

(40768446) Kidney Pathology biopsy report

383

1.02

0.01

1.7

1.6

—

(3042733) HLA Ab [Presence] in Serum

364

1.02

0.00

4.0

4.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

934

1.01

0.00

1.1

98.65

96.46

0.36

880

(3001964) Herpes simplex virus Ag [Presence] in Specimen

273

0.99

0.00

1.4

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

225

1.02

0.00

1.1

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

101

1005

1.01

0.00

1.4

58328.75

55614.71

e6/l

0.03

588

(3003434) Protein [Mass/volume] in Pleural fluid

126

1255

1.00

0.00

1.4

31.89

34.61

g/l

1.54

113

1138

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

142

0.99

0.00

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

142

0.99

0.00

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

142

0.99

0.00

1.4

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

152

0.99

0.00

2.3

2.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

188

1.01

0.00

2.4

2.3

6.43

7.91

mmol/l

1.25

109

(3024471) HLA-A [Type]

372

0.99

0.00

1.0

—

(40757373) Influenza virus identified in Isolate

189

1.01

0.00

1.5

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.88

0.00

1.6

1.4

387.40

323.42

umol/24h

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.94

-0.00

1.2

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

0.92

-0.00

2.7

1.5

89.00

112.81

ug/l

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.02

-0.00

2.0

1.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.99

-0.00

1.3

1.1

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.42

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.94

-0.00

1.7

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.93

-0.00

1.0

1.1

1.00

1.11

u/field

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.88

-0.00

2.5

2.0

—

(3022475) Manganese [Moles/volume] in Blood

0.88

-0.00

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.94

-0.00

1.2

—

(40758358) Immune stain study

0.94

-0.00

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.92

-0.00

7.8

5.5

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

52.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_IMPINGEMENT and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_IMPINGEMENT	0.712 [0.65, 0.78]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.799

During the follow-up period (1.1.1998 — 31.12.2019), 1977 out of 33106 females with M13_IMPINGEMENT died.

Males

Parameter	HR [95% CI]	p-value
M13_IMPINGEMENT	0.762 [0.7, 0.83]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 3529 out of 34481 males with M13_IMPINGEMENT died.

Mortality risk

Mortality risk for people of age

years, who have M13_IMPINGEMENT.

N-year risk	Females	Males
1	0.072%	0.131%
5	0.433%	0.845%
10	1.203%	2.165%
15	2.292%	4.11%
20	4.023%	7.094%

Relationships between endpoints

↥

Index endpoint: M13_IMPINGEMENT – Impingement syndrome of shoulder

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Impingement syndrome of shoulder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints